Nucleotide Excision Repair Through the Looking Glass by Ribeiro-Silva, C. (Cristina)
NUCLEOTIDE EXCISION REPAIR
THROUGH THE LOOKING GLASS
CRISTINA
RIBEIRO-SILVA
NUCLEOTIDE EXCISION REPAIR
 THROUGH THE LOOKING GLASS
CRISTINA RIBEIRO-SILVA
2020

543301-L-sub01-bw-Silva
Processed on: 6-5-2020 PDF page: 1
Nucleotide excision repair 
through the looking glass
Cristina Ribeiro-Silva
543301-L-sub01-bw-Silva
Processed on: 6-5-2020 PDF page: 2
Colophon
ISBN: ISBN: 978-94-028-2015-7
Cover design: Ovidiu Stanciu & Cristina Ribeiro-Silva
Layout: Cristina Ribeiro-Silva
Printed by: Ipskamp Printing
Copyright © Cristina Ribeiro-Silva 2020, Rotterdam, The Netherlands
All rights reserved. No part of this thesis may be reproduced, stored or transmitted 
in any form or by any means without the prior written permission of the author or 
from the publishers holding the copyright of published articles. 
543301-L-sub01-bw-Silva
Processed on: 6-5-2020 PDF page: 3
Nucleotide excision repair 
through the looking glass
Nucleotide excisiereparatie onder de loep
 
Thesis
to obtain the degree of Doctor from the
Erasmus University Rotterdam
by command of the
rector magnificus
Prof. dr. R.C.M.E. Engels
and in accordance with the decision of the Doctorate Board.
The public defense shall be held on 
Tuesday, 9th June 2020 at 15:30 hrs
by
Ana Cristina Ribeiro da Silva
Born in Lisbon, Portugal 
Erasmus University Rotterdam 
543301-L-sub01-bw-Silva
Processed on: 6-5-2020 PDF page: 4
Doctoral Committee
Promoter: Prof. dr. W. Vermeulen
Other members: Prof. dr. H. van Attikum
Dr. ir. J.A.F. Marteijn 
Dr. T. Mahmoudi
Copromoter: Dr. H. Lans 
543301-L-sub01-bw-Silva
Processed on: 6-5-2020 PDF page: 5
TABLE OF CONTENTS 
Chapter 1
Chapter 5
Chapter 2
Chapter 6
Chapter 3
Appendix (&)
Chapter 4
General introduction & 
scope of the thesis
SWI/SNF: Complex complexes 
in genome stability and cancer
DNA damage sensitivity 
of SWI/SNF-deficient cells 
depends on TFIIH subunit 
p62/GTF2H1
Concluding remakrs & 
future directions
Ubiquit in and TFIIH-
stimulated DDB2 dissociation 
drives DNA damage hand-
over in nucleotide excision 
repair
Summary
Samenvatting
Curriculum vitae
List of publications
PhD portfolio
Acknowledgements
ATP-dependent chromatin 
remodeler CHD1 promotes 
nucleotide excision repair
7
149
33
177
79
193
119
543301-L-sub01-bw-Silva
Processed on: 6-5-2020 PDF page: 6
543301-L-sub01-bw-Silva
Processed on: 6-5-2020 PDF page: 7
General introduction &
scope of the thesis
1
543301-L-sub01-bw-Silva
Processed on: 6-5-2020 PDF page: 8
Chapter 1
8
Introduction
DNA damage 
DNA lesions are a fact of life. It is estimated that, daily, each of our 
cells is confronted with approximately 104-105 new DNA lesions1,2. Left 
unrepaired, these lesions can interfere with essential genome processes, 
such as transcription and replication3,4, having immediate and long term 
consequences. For instance, lesions in the transcribed strand of genes 
halt transcription and directly interfere with gene expression, which, on 
the long term, favors progeria following damage-induced senescence 
or apoptosis. Meanwhile, erroneous replication of a damaged DNA 
template can introduce mutations that alter genetic information and can 
lead to aberrant chromosome segregation, both contributing to genome 
instability4–7. Although very rarely mutations turn out to be beneficial to the 
organism, i.e., when they favor biodiversity and adaptive evolution, most 
often mutations are the hallmark for genetic disease and tumorigenesis. 
DNA integrity and the proper functioning of the genome are liable to 
insults arising from multiple sources that directly damage the DNA, among 
which are: 1) (by)products of our cellular metabolism, such as reactive 
oxidative and nitrogen species, alkylating and lipid peroxidation products; 
2) spontaneous chemical instability of DNA under physiological conditions, 
such as base hydrolysis and deamination; and 3) external/environmental 
agents such as ultra-violet (UV) light, ionizing radiation and numerous 
harmful chemicals1,7,8. Because DNA is the only biomolecule that is never 
completely renewed throughout a cell’s lifetime, its integrity relies solely 
on the repair of existing molecules to safeguard its faithful expression and 
the transmission of genetic information to the next generations. 
DNA repair: a multiplex response to numerous constant threats 
Cells utilize a range of specialized DNA damage repair mechanisms, 
signaling pathways, tolerance processes and cell cycle checkpoints, 
collectively called the DNA damage response (DDR), to cope with DNA 
injuries9. Depending on the type of damage, the location of the damage 
in the genome, the type of cell and the cell cycle stage, a specific pathway 
of the DDR is activated. By transiently halting cell cycle progression, these 
genome caretaking tools can provide cells with a time window for repair 
to prevent lesion-induced mutagenesis and chromosome missegregation 
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during replication and mitosis, respectively. Alternatively, rather than 
halting the cell cycle, replication-blocking lesions can be temporarily 
ignored to allow cell cycle progression if that is more convenient to 
cell survival. Under these circumstances, the activation of DNA damage 
tolerance pathways allows alternative DNA polymerases, in a process 
called translesion synthesis (TLS), to bypass the lesion at the expense 
of fidelity. In addition, to prevent tumorigenesis, cells with too extreme 
damage load can be directed into apoptosis. Genetic diseases, neurological 
degeneration, premature aging and increased cancer susceptibility are 
severe fallouts of inherited DDR defects that illustrate the human’s health 
reliance on an operational DDR3,4,9,10. 
The crux of the cell’s defense against DNA damage is embodied by a 
range of complementary DNA repair mechanisms able to recognize and 
remove most types of DNA damage (Fig. 1)4,9. DNA mismatch repair 
(MMR), base excision repair (BER) and nucleotide excision repair (NER) 
have similar strategies to remove DNA lesions that affect only a single 
DNA strand, relying on the excision of one or more bases by nucleases 
including the damaged base(s). The ensuing gap is filled and closed by 
DNA polymerases and ligases, respectively, with newly synthesized DNA 
using the complementary and undamaged strand as template. MMR is 
mainly active during replication and prevents mutagenesis by removing 
misincorporated bases or small insertion or deletion loops caused 
by replicative slipage11,12. BER protects organisms from accumulating 
endogenous DNA damage induced by free radicals and other reactive 
chemicals derived from the cell’s metabolism and environment sources. 
Particularly, BER can repair oxidized, deaminated or alkylated nucleotides 
that do not significantly disturb Watson-Crick base pairing1,13. In BER, 
lesion-specific DNA glycosylases recognize and excise the damaged base 
by cleaving the N-glycosidic bond between the base and the deoxyribose, 
leaving an apurinic/apyrimidinic (AP) site. Subsequent incision of the 
deoxyribose by APE1 generates a single-strand break that is repaired by 
DNA synthesis of a single nucleotide (short-patch BER) or a longer stretch 
of nucleotides (long-patch BER) 14,15. Single-strand breaks are repaired 
in a similar manner involving BER proteins. Helix-distorting lesions, such 
as UV-induced photoproducts and intrastrand crosslinks are repaired by 
NER, described below in more detail as this process is the main focus of 
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this thesis. 
Two major pathways facilitate the repair of more destructive lesions, such as 
double-strand breaks (DSBs). These lesions affect both strands of the DNA 
helix and can arise, for instance, from replication fork stalling or collapse 
(e.g., after chemotherapeutic drug treatment), enzymatic incisions (e.g., by 
Cas9 or during class switch recombination in developing lymphocytes), or 
exposure to ionizing radiation (IR, e.g., X-rays). DSBs are resolved mainly 
by homologous recombination (HR) or non-homologous end-joining 
(NHEJ), depending on the cell cycle stage and the genomic location of the 
break. While NHEJ re-ligates broken ends throughout all phases of the 
cell cycle16,17, this process is considered to be error-prone since the two 
strands are processed before ligation, which may result in the removal 
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Figure 1. DNA damage, repair pathways and DNA damage consequences. (a) Overview of common 
endogenous and environmental DNA damaging agents, examples of DNA lesions induced by these and 
the most relevant repair pathways cells used to remove each type of lesion. Abbreviations: HR, homologous 
recombination; NHEJ, non-homologous end-joining; FA, fanconi anaemia; NER, nucleotide excision repair; 
MMR, mismatch repair; BER, base excision repair. (b) DNA damage-induced transient arrest of cell-cycle 
phases, G1, S, G2 or M, interruption of DNA metabolism processes, e.g., transcription, replication and 
chromosome segregation, and long-term consequences of DNA damage, including mutations and 
chromosome aberrations and their biological effects. 
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or addition of several nucleotides. HR is only active during the S and G2 
phases of the cell cycle as it employs the intact sister chromatid as a repair 
template to repair the break in an error-free manner. During HR, trimming 
the two DNA ends creates 3’ overhangs that invade the sister chromatid 
which is then used as a template to synthesize any missing DNA. Specific 
endonucleases help resolve the Holliday junction structure and the nicks 
are finally ligated back together16–18. 
Other destructive and more complex lesions are interstrand crosslinks 
(ICLs), which form covalent bonds between the two DNA strands. ICLs can 
be induced by chemicals such as the chemotherapeutic drug cisplatin, and 
are extremely toxic as they block transcription and replication19. Moreover, 
because repair of these lesions requires the repair of both strands, they 
are particularly challenging for cells to deal with and collaborative efforts 
of multiple DDR repair mechanisms are therefore required16. The cell 
cycle stage dictates the choice of a particular repair response, but the 
exact mechanisms in place are still poorly understood. In S phase, stalled 
replication forks due to ICLs are recognized by the Fanconi anemia (FA) 
pathway proteins that orchestrate, via incision, the unhooking of the 
ICL from one of the DNA strands. The repair reaction is finalized by the 
activities of other DDR mechanisms, including TLS20, HR21 and NER22. TLS 
fills the gap in the complementary DNA strand opposite of the unhooked 
crosslink, which is then used by HR as template to repair the DSB in the 
incised DNA23. NER is thought to repair the unhooked crosslink, and has 
also been implicated, together with TLS, in the removal of ICLs in non-
replicating cells24,25. 
Nucleotide excision repair
NER is unique in its ability to repair a wide range of lesions that arise from 
diverse and different genotoxic insults because, in contrast to most other 
DNA repair pathways, NER detects the structural consequences of DNA 
damage, i.e.,  helix-destabilization, instead of the DNA lesion itself26. These 
helix-distorting lesions include the UV-induced cyclobutane pyrimidine 
dimers (CPDs) and pyrimidine-pyrimidone (6–4) photoproducts (6-4PPs), 
ROS-induced cyclopurines, chemically-induced bulky adducts and 
chemotherapy drug-induced (e.g., cisplatin) intrastrand crosslinks27,28. 
More than 30 proteins are involved in the intricate network of NER, 
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and cooperate to perform four essential steps: 1) damage detection; 2) 
damage verification; 3) excision of a single-stranded DNA segment; and 
4) DNA synthesis and ligation to restore the gap. Depending on where in 
the genome lesions occur, two different damage detection sub-pathways 
can initiate NER. Transcription-coupled repair (TC-NER) detects lesions 
in the transcribed strand of active genes10,28, whereas global genome 
repair (GG-NER) detects lesions anywhere in the genome. The biological 
significance of the NER pathway is clinically evident from a range of 
different cancer-prone, developmental and/or progeroid disorders that 
arise from specific hereditary NER deficiencies10,28. 
DNA damage detection by TC-NER
Transcription blocking lesions compromise cellular viability and function 
and promote premature (DNA-damage induced) aging, as a consequence 
of lower gene expression and increased apoptosis10,28,29. To counteract 
the cytotoxic effects of these lesions that stall RNA Polymerase II (Pol 
II) molecules, TC-NER is activated with the recruitment of CSB, CSA and 
UVSSA proteins28,30 (Fig. 2a). The transient interaction between CSB and 
Pol II during transcription is stabilized when Pol II cannot be pushed 
forward by the helicase/translocase activity of CSB due to a transcription-
blocking lesion31,32. CSA, which is part of the larger E3 ubiquitin ligase 
CRL4CSA complex, is recruited to the lesion by CSB and directs the poly-
ubiquitylation and proteasomal degradation of CSB following UV 
irradiation33,34. Subsequent binding of UVSSA, assisted by the histone 
chaperone FACT and stabilized by CSA, counteracts CSB degradation and 
stabilizes its binding to the lesion site by recruiting the de-ubiquitylation 
enzyme USP730,35–37. UVSSA also recruits transcription factor IIH (TFIIH) via 
direct interaction with TFIIH’s subunit GTF2H1 (also known as p62)35,38.  
DNA damage detection by GG-NER
The great majority of helix-destabilizing DNA lesions are detected by 
GG-NER, which examines the entire genome, coding and non-coding, 
for severe DNA damage-induced helix distortions27,28. XPC, as part of the 
heterotrimeric XPC-CETN2-RAD23B complex39–41, is capable of detecting 
a broad range of structurally unrelated lesions. XPC employs an indirect, 
stepwise damage recognition and binding mode, in which transient 
interactions with DNA precede the formation of a stable and immobile 
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DNA-bound complex42–45. While XPC diffuses through the nucleus, it probes 
the DNA for lesions that thermodynamically destabilize the DNA double 
helix and disrupt Watson-crick pairing. Without contacting the lesion 
directly, XPC becomes fully and stably bound to the extruding nucleotides 
in the undamaged strand44,46,47. TFIIH is recruited by interactions between 
its helicase XPB and core GTF2H1 subunits with XPC38,48,49. Because XPC also 
detects mismatches and aberrant DNA structures that are not processed 
by NER, examination by TFIIH of whether genuine DNA damage is present 
plays a crucial role in ensuring the fidelity of the NER reaction (described 
in more detail below). 
Despite being the main damage sensor in GG-NER, XPC requires the 
auxiliary function of the UV-DDB complex, comprising DDB1 and DDB2, 
to efficiently recognize UV-induced photolesions47,50,51. In particular, 
UV-induced CPDs are poor substrates for XPC since they only mildly 
destabilize the DNA helix40,52,53. To enable their repair, DDB2 stimulates XPC 
recruitment by directly binding and flipping out the damaged bases, which 
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Figure 2. DNA damage detection in NER. (a) TC-NER is initiated when an elongating RNA Pol II molecule 
is stalled by a lesion in the transcribed strand of an active gene, leading to the increased binding and 
recruitment of TC-NER factors CSB, CSA (as part of the CRL4CSA complex), UVSSA and USP7. (b) In GG-NER, 
damage detection is carried out by XPC which probes the DNA for helix-distorting lesions, in complex with 
RAD23B and CETN2 proteins. DDB2, in complex with DDB1 as part of the CRL4DDB2 complex, binds specifically 
to UV-induced lesions and facilitates recognition of DNA damage by XPC, in particular CPDs, which only 
mildly destabilize the DNA helix. The E3 ubiquitin ligase CRL4DDB2 ubiquitylates DDB2 and XPC to regulate 
their affinity and binding to damaged DNA.
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then become a suitable substrate for XPC54 (Fig. 2b). The UV-DDB complex 
is part of a larger E3 ubiquitin-ligase complex (CRL4DDB2), containing CUL4A, 
RBX1, and the COP9 signalosome55. The binding of DDB2 to UV-lesions 
triggers the COP9 signalosome dissociation, which stimulates the E3 
ubiquitin-ligase activity of the complex33,55,56. The main targets of the E3 
ubiquitin-ligase activity of the complex are core histones H2A, H3 and 
H4, XPC and DDB2 itself55,57–59. While ubiquitylation of DDB2 decreases its 
affinity to UV-DNA lesions and targets DDB2 for proteasomal degradation, 
ubiquitylation of XPC increases XPC’s affinity to DNA lesions in vitro58,60. 
DNA damage binding of both DDB2 and XPC is tightly regulated by post-
translational modifications (PTMs), such as SUMOylation61, ubiquitylation62 
and PARylation63–65. DNA damage handover from DDB2 to XPC and TFIIH 
is further described and studied in more detail in Chapter 3. 
Core NER reaction: damage verification, dual incision and gap filling
Once damage has been detected by either TC- or GG-NER, both 
pathways converge into the same repair mechanism by recruiting TFIIH. 
TFIIH is loaded on the damaged strand 5’ to the lesion, through a direct 
interaction with either XPC (via GG-NER) or UVSSA (via TC-NER)35,38,48,49. 
TFIIH is a multifunctional complex that opens the DNA helix in both NER66 
and transcription initiation67. The helicase XPB facilitates recruitment of 
TFIIH to DNA damage68,69, whereas the XPD helicase verifies the presence 
of genuine NER substrates by unwinding the DNA in 5ʹ–3ʹ direction while 
scanning for helicase blocking lesions66,70. In the absence of damage-
stalled XPD, repair is aborted66,71. The TFIIH complex is composed of ten 
subunits, all of which are necessary for its stability72–75. In Chapter 276, we 
describe how SWI/SNF ATPases BRM and BRG1 promote transcription of 
TFIIH subunit GTF2H1, thus enabling TFIIH function in transcription and 
NER. 
Damage verification is stimulated by the DNA damage binding protein 
XPA, which binds to nucleotides with altered chemical structures in 
ssDNA77. XPA stimulates the release of the transcription-associated CAK 
subcomplex from TFIIH, consequently stimulating the helicase activity 
of XPD70,78,79. Besides stimulating lesion verification by TFIIH, XPA also 
interacts with many core NER proteins27,80, likely for optimal positioning 
of the NER endonucleases for incision81. For this reason, XPA is considered 
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to be a central coordinator of the NER reaction. The RPA protein complex, 
after damage verification, binds to single-stranded DNA to protect the 
non-damaged DNA strand from endonucleases. Together, XPA and RPA 
orient the two structure-specific endonucleases ERCC1-XPF and XPG to the 
damaged strand82–84. XPG recruitment (independently or simultaneously 
with TFIIH83,85) enables the first incision, 5’ to the lesion, by ERCC1-XPF, 
and the dual incision is then finalized by XPG itself, 3’ to the lesion84. 
The generated 22-30 nucleotide ssDNA is released, most likely together 
with TFIIH, and degraded86. The final DNA gap filling step involves the 
recruitment of RFC, PCNA, either DNA polymerase δ (non-replicating 
cells), ε (mainly in replicating cells) or κ (non-replicating cells)87–90 for de 
novo DNA synthesis using the undamaged strand as template, and the 
recruitment of either DNA ligase I or III to seal the gap88 (Fig. 3). 
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Figure 3. Core NER mechanism. After 
detection of DNA damage by either GG- or 
TC-NER, both pathways converge to a common 
core mechanism. The recruitment of TFIIH, via 
an interaction with XPC (in GG-NER) or with 
UVSSA (in TC-NER), results in the release of 
its transcription-associated CAK subcomplex, 
stimulated by XPA. The active helicase 
activity of TFIIH opens the double helix and 
verifies the presence of a lesion. XPA and 
RPA binding to the altered nucleotides in the 
single-stranded DNA and to the undamaged 
strand, respectively, facilitate the loading of 
the structure specific endonucleases ERCC1-
XPF and XPG (recruited independently or 
simultaneously with TFIIH) to the damaged 
strand. ERCC1-XPF incision 5’ of the lesion is 
followed by XPG 3’ incision, resulting in the 
excision of a 22-30 oligonucleotide containing 
the DNA lesion. The first incision, by ERCC1-
XPF, enables the PCNA-assisted gap-filling by 
DNA polymerases δ, ε or κ. DNA ligases I or 
III seal the nick and complete the DNA repair 
reaction. 
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Chromatin as an integral player in the DDR 
Mammalian cells are capable of storing our genome in the constricted 
volume of their nucleus by condensing DNA and wrapping it around nuclear 
proteins in a DNA-protein complex defined as chromatin. Every 146/147 
bp of DNA wrapped by a histone octamer with two copies of histones 
H2A, H2B, H3 and H491 forms the basic unit of chromatin, the nucleosome. 
The electrostatic interactions between the phosphate backbone of the 
DNA and positively charged histones stabilize nucleosomes, while the 
linker DNA segments connect nucleosomes together. Additional short- 
and long-range interactions and histone H1 play an important role in 
stabilizing coiled higher-order chromatin structures91. In addition to its 
role in condensing and storing the DNA in the nucleus, chromatin serves 
as a way to control how DNA is used. For instance, processes such as 
transcription and replication require the access of specialized proteins to 
specific parts of the DNA. It is thus important that chromatin is modified 
to regulate the access of proteins to DNA during these processes, while 
it simultaneously serves as a transaction platform that regulates signaling 
events and protein docking during DNA transacting events. 
Generally speaking, two major mechanisms control wrapping of DNA into 
nucleosomal units. The first involves histone modifiers that catalyze the 
covalent attachment or removal of functional groups or small proteins 
to protruding histone tails. These PTMs change the chemical properties 
of histones and/or change how histones interact with the DNA92 or other 
proteins. The many flavors and forms of PTMs combined serve as docking 
ATP
Unwrapping
Sliding Eviction
ADP
ATP-dependent 
chromatin remodeling 
complexes
Figure 4. Schematic representation of 
ATP-dependent chromatin remodelling 
mechanisms. ATP-dependent chromatin 
remodelling complexes use distinct ways 
to rearrange chromatin at the expense of 
ATP. To alter the contacts between DNA and 
nucleosomes, these remodelers can unwrap, 
reposition (sliding) or evict nucleosomes, or 
alter their histone composition by replacing 
or ejecting histones. 
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and signaling sites for many chromatin related proteins. Examples of 
these chemical PTMs on histones include methylation, acetylation, 
phosphorylation, ubiquitylation, SUMOylation and PARylation, which 
also play important roles in the DDR93. The second major mechanism in 
DNA wrapping involves ATP-dependent chromatin remodeling proteins/
complexes that catalyze the disruption of DNA-histone contacts using 
the energy from ATP hydrolysis to slide, evict, unwrap nucleosomes or 
alter their composition94–96 (Fig. 4). In mammals, many structurally related 
chromatin remodeling proteins and complexes have been identified, 
including the SWI/SNF, CHD, ISWI and INO80 families. The SWI2/SNF2 
superfamily of ATP-dependent chromatin remodelers is characterized by 
an ATPase domain consisting of two subdomains, DExx and HELICc94. In 
addition to the split SWI2/SNF2 ATPase domain, each member of these 
families contains specific but different additional functional domains 
within or adjacent to the ATPase domains94,96,97 (Fig. 5). The composition of 
these protein complexes is highly dynamic and may vary according to cell 
type, cell cycle stage or the event in place. 
Figure 5. Schematic representation of the mammalian SWI2/SNF2 superfamily of ATP-dependent 
chromatin remodelers. The SWI2/SNF2 superfamily is characterized by an ATPase domain split in two parts: 
DExx and HELICc. The unique additional domains each subfamily member harbors within or adjacent to its 
ATPase domain, determines its specificity and classification into SWI/SNF, CHD, ISWI or INO80. The HSA and 
BR domains allow the SWI/SNF family to bind nuclear actin-related proteins as well as acetylated lysines, 
respectively. CHD chromatin remodelers contain a tandem chromodomain positioned at the N-terminus, 
which enables the binding to methylated lysines. The ISWI family has three domains (HAND, SANT and 
SLIDE) which mediate interactions with proteins and DNA. The INO80 family has a longer insertion between 
the split ATPase domains. 
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Many studies have shown that both chromatin modifying and ATP-
dependent chromatin remodeling enzymes are involved in the mammalian 
DDR. In the past years, the number of chromatin remodelers that are 
implicated in the DDR has substantially increased, indicating that (re)-
organization of chromatin structure is an intricate and essential component 
of the DDR in vivo93,98–101. In Chapter 276, we study the specific involvement 
of SWI/SNF proteins in NER, while in Chapter 5102 we review their known 
functions in the DDR. In addition, a novel role for CHD1 in NER is described 
in Chapter 4. Deficiencies in both ATP-dependent chromatin remodelers103 
and DDR4 are linked to tumorigenesis, but the interplay between these 
two deficiencies and how they contribute to cancer development is still an 
active field of research. 
The access, repair and restore model revised
A central question in the field of DNA repair is how, within the dynamic 
structure of chromatin where the lesion occurs, multi-subunit complexes 
can recognize and repair DNA lesions at any given moment and genomic 
location104–106. Conversely, chromatin itself is subject to regulation during 
DNA repair. Approximately four decades ago, the observations by 
Smerdon and colleagues laid the foundations for a model of DNA repair 
within the context of chromatin, referred to as “access, repair and restore” 
(ARR)107,108. The model suggested that chromatin changes are required for 
repair to take place, first by becoming more accessible to facilitate DNA 
damage recognition and second, after DNA repair is completed, to restore 
its original conformation107–110. Pioneer observations of increased DNA 
accessibility following UV-C irradiation of human fibroblasts compelled a 
thorough examination of the phenomenon. Regions undergoing repair by 
NER were found to be transiently more sensitive to MNase digestion108,111 
and to only recover their nuclease resistance over time108. Similar results 
were observed with restriction enzymes112 and DNase I digestion of 
UV-damaged chromatin113,114. Although the initial major observations of 
nucleosome rearrangements were done in the context of repair by NER 
following UV-C irradiation, similar chromatin changes were soon observed 
following exposure to different kinds of DNA damaging agents115,116. 
Follow-up efforts showing that nucleosomes were refractory to NER117–
119 but also to DSB repair120 and that both local and global relaxation of 
chromatin takes place upon DSB induction121–124 solidified the premise of 
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the ARR model, that is of active chromatin remodeling before DNA repair. 
Since then, the principles of repair within chromatin have broadened to 
include other DNA repair mechanisms. 
However, the view of chromatin as a mere obstacle to DNA repair is 
evolving125. Many chromatin proteins whose function is associated 
with chromatin condensation, including polycomb proteins and 
heterochromatin proteins 1 (HP1), are transiently recruited to DSB and 
stimulate repair109,126–128, partly by repressing transcription at DSBs129–131. 
HP1 proteins are also recruited to UV-induced DNA damage and their loss 
results in increased sensitivity to UV irradiation132. Although this challenged 
the original idea of the ARR model, it is consistent with studies showing 
that heterochromatin is not refractory to the diffusion of large proteins133 
and presented grounds for considering chromatin – and chromatin-
associated factors/enzymes – as an integral part of the DDR. A recent 
proposed model revises the “access” step as an “access & priming” step 
instead, where chromatin also acts as a platform promoting the assembly 
of signaling and repair machineries in competent DDR regions109,125 (Fig. 6). 
This priming step may contribute to the regulation of DNA repair pathway 
choice or coordination between the DDR and nuclear events to suppress 
Nucleosome 
destabilization
New histone 
deposition
DNA lesion
ATP-dependent 
chromatin 
remodelers
Histone modifiers
Histones
Chaperones
Repair
Access 
Prime
Repair
Restore
Figure 6. The revised 
access/pr ime-repair/
r e s t o r e  m o d e l .  I n 
this s implif ied model 
representation, histone 
modifiers, chaperones and 
ATP-dependent chromatin 
r e m o d e l e r s  r e s h a p e 
d a m a g e d  c h r o m a t i n 
by unfolding, refolding 
and reposit ioning of 
nucleosomes during repair. 
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mutagenic events and limit their oncogenic potential93,109,125. 
Many histone modifiers, chaperones and chromatin remodeling 
complexes have been suggested to promote or, at least to some degree, 
modulate repair of UV-damaged DNA. Although SWI/SNF proteins confer 
UV-resistance to the model organism C. elegans134 and mammalian cells, 
literature presents discrepant evidence regarding which step in NER SWI/
SNF proteins regulate135–139. BRG1 and SNF5 are the most researched 
subunits; therefore, in Chapter 276, we investigated the putative role of 
BRM in NER. The mammalian INO80 complex was reported to facilitate the 
repair of 6-4PPs and CPDs140 and, like the ALC1 chromatin remodeler64, may 
function to facilitate damage detection by GG-NER, while the ISWI subunit 
SMARCA5 is required for TC-NER141. Surprisingly, not much is known 
regarding CHD proteins and the UV-DDR142. Consequently, in Chapter 4 
we explored a putative function for CHD1 in NER. The histone chaperones 
FACT143, HIRA144 and CAF-1145–147 were also shown to be recruited to UV-C 
damaged chromatin. Interestingly, the direct interaction between CAF-1 
and PCNA couples histone deposition (i.e., chromatin re-assembly) with 
repair-associated DNA synthesis146, as part of a concerted process. 
 
How the individual - and likely cooperative - action of these chromatin-
modifying proteins contributes to the UV-DDR is still, unfortunately, 
unclear. The lack of clear follow-up studies leaves many questions open. 
Although studies in yeast have clearly shown that chromatin remodeling 
facilitates NER142,148,149, it remains to be investigated whether the function 
of ATP-dependent chromatin remodeling enzymes during mammalian 
NER is actual chromatin remodeling activity or an uncharacterized activity. 
ATP-dependent chromatin remodelers have many cellular functions, 
making it a challenge to disentangle those functions from their activities 
in the DDR. Furthermore, they appear to act differently in different repair 
pathways99. A current and future challenge, therefore, lies in decoding the 
precise activities, at the molecular level, of the many different chromatin 
modifying and remodeling proteins proposed to act in DDR and to 
understand how these act together at the same lesion to facilitate DNA 
repair. 
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Scope of this thesis
Likely most essential NER enzymes have been identified and the basic NER 
steps are accurately defined. Nevertheless, NER is thought to be tightly 
regulated by multiple PTMs and chromatin-modifying enzymes in vivo, 
of which the precise mechanisms are still largely not understood. The 
research presented in this thesis combined cell biology, biochemistry and 
microscopy methods to obtain a more comprehensive understanding of 
NER in intact and living cells, by studying the interplay between NER factors 
themselves and with ATP-dependent chromatin remodeling proteins. 
Inactivating mutations in SWI/SNF proteins are amongst the most common 
mutations across chromatin remodeling enzymes in all human cancers. 
SWI/SNF proteins have been implicated in different DDR pathways, 
but conflicting observations have made it difficult to define a unified 
mechanism by which SWI/SNF acts in NER. In Chapter 2, we describe 
why the two SWI/SNF ATPases, BRM and BRG1, are necessary for efficient 
NER. Both BRM and BRG1 promote the expression of the essential TFIIH 
subunit GTF2H1 and, consequently, the stability and functionality of the 
TFIIH complex itself, both in transcription and in NER. In this chapter, we 
furthermore contemplate the potential of this finding, suggesting that 
SWI/SNF-deficiency-induced DDR-vulnerability could be exploited for 
precision cancer therapy. 
The dynamic arrangement of NER factors entails temporal and spatial 
coordination for each NER protein and step, in order for efficient 
restoration of damaged DNA to take place. Despite the fact that multiple 
PTMs have been found to regulate the activity of GG-NER damage sensor 
proteins DDB2 and XPC, it remained unclear how their activity in detecting 
and handing over DNA damage to TFIIH is coordinated. In Chapter 3, 
we studied the interplay between the recruitment and dissociation of 
DDB2, XPC and TFIIH to UV-induced DNA damage. We show that timely 
DDB2 dissociation, after damage recognition by XPC, is as important as 
its recruitment to DNA lesions. Dissociation of DDB2 is required for DNA 
damage handover to XPC, and coincides with the arrival of the TFIIH 
complex and the formation of a stable XPC-TFIIH complex, which further 
stimulates DDB2 dissociation. CRL4DDB2-mediated ubiquitylation of DDB2 
following UV irradiation plays a major role in this damage handover, as 
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it promotes DDB2 dissociation and extraction from chromatin, DDB2 
proteolytic degradation and, ultimately, prevents excessive DDB2 binding 
to lesions. Overall, our results demonstrate how the elegant interplay 
between GG- and core NER factors - which cooperate but also compete 
with one another - contributes to the correct spatiotemporal control of 
NER. 
Several ATP-dependent chromatin remodeling proteins from the CHD 
family have been implicated in DSB repair, but their role in NER has hardly 
been investigated. Loss of CHD1 sensitizes cells to a range of DNA damage 
agents that induce helix-distorting DNA crosslinks mainly processed by 
NER. Due to the high mutation frequency of CHD1 in prostate cancer, 
a better understanding of CHD1 function in tumorigenesis and DDR 
may provide a rationale for new therapeutic avenues exploiting CHD1 
vulnerabilities caused by CHD1 loss. Therefore, in Chapter 4, we sought 
to explore the putative role of CHD1 in NER. We found that CHD1 is likely 
a novel regulator of NER as its activity is required for optimal survival 
following UV irradiation. Furthermore, CHD1 is required for the DNA 
damage loading of late NER factors, such as XPF, but not earlier proteins 
such as DDB2, XPC, TFIIH and XPA. Instead of favoring damage handover in 
the early steps of the reaction, CHD1 appears to promote the progression 
from lesion verification to excision. Our findings endorse further research 
to clarify CHD1’s specific contributions in NER and their overall impact on 
DDR and health. 
Defects in both ATP-dependent chromatin remodelers and DDR are 
linked to tumorigenesis, but how the interplay between these defects 
promotes cancer development is only partially understood. In Chapter 5, 
we review the emerging functions of SWI/SNF ATP-dependent chromatin 
remodelers in DSB repair and NER, in light of our findings in Chapter 2, the 
DDR-related vulnerabilities that arise from SWI/SNF dysfunction and their 
potential application in precision cancer therapy. 
In Chapter 6, we summarize and discuss the main findings of the 
experimental work described in Chapter 3 and Chapter 4 and provide 
future directions to study in-depth the implications of fine-tuning GG-NER, 
as well as to dissect CHD1’s molecular function in NER. 
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Abstract
Mutations in SWI/SNF genes are amongst the most common across 
all human cancers, but efficient therapeutic approaches that exploit 
vulnerabilities caused by SWI/SNF mutations are currently lacking. 
Here, we show that the SWI/SNF ATPases BRM/SMARCA2 and BRG1/
SMARCA4 promote the expression of p62/GTF2H1, a core subunit of the 
Transcription Factor IIH (TFIIH) complex. Inactivation of either ATPase 
subunit downregulates GTF2H1 and therefore compromises TFIIH stability 
and function in transcription and nucleotide excision repair (NER). We also 
demonstrate that cells with permanent BRM or BRG1 depletion have the 
ability to restore GTF2H1 expression. As a consequence, the sensitivity 
of SWI/SNF-deficient cells to DNA damage induced by UV irradiation 
and cisplatin treatment depends on GTF2H1 levels. Together, our results 
expose GTF2H1 as a potential novel predictive marker of platinum drug 
sensitivity in SWI/SNF deficient cancer cells. 
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Introduction
Compiled sequencing efforts have revealed the high prevalence of 
mutations in chromatin remodeling genes across many different types 
of cancer1,2. Inactivating mutations in subunits of the SWI/SNF ATP-
dependent chromatin remodeling complexes are amongst the most 
frequently mutated genes in human cancers3,4, which argues for a major 
role in cancer pathogenesis. SWI/SNF complexes contain one of two 
mutually exclusive catalytic ATPase subunits, BRM/SMARCA2 or BRG1/
SMARCA4, and multiple core and accessory subunits that together form a 
variety of functionally distinct complexes5. BRM and BRG1 use the energy 
of ATP to remodel chromatin, through which they regulate transcription, 
DNA damage repair (DDR) and replication and impact a variety of cellular 
processes including cell differentiation and growth1,5,6. 
Mutations in SWI/SNF subunits result in aberrant chromatin structures, 
increased genomic instability and perturbation of transcriptional programs, 
which are all hallmarks of cancer that can contribute to cell transformation 
and tumorigenesis1,5–7. Because the products of these typically loss-
of-function mutations do not constitute obvious drug targets, efficient 
therapeutic strategies to target tumor cells with mutant SWI/SNF genes 
are still lacking. Detailed insight into the molecular mechanisms of the 
many anti-tumorigenic cellular functions of SWI/SNF is required in order 
to develop such strategies.
SWI/SNF proteins have been implicated in multiple DDR mechanisms, 
including double strand break (DSB) repair and nucleotide excision 
repair (NER), and are thought to coordinate signaling and efficient 
recruitment of repair proteins to chromatin6,8,9. NER removes a wide 
range of structurally unrelated helix-distorting DNA lesions, including 
cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts (6-4PPs) 
induced by UV-light, ROS-induced cyclopurines and intrastrand crosslinks 
generated by chemotherapeutic platinum drugs10,11. If not repaired, these 
lesions interfere with transcription and replication, which can result in 
cell death or lead to mutations and genome instability that contribute 
to oncogenesis. Depending on the location of DNA lesions, two distinct 
DNA damage detection mechanisms can trigger NER. Transcription-
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coupled NER (TC-NER) is initiated when RNA Polymerase II is stalled 
by lesions in the transcribed strand and requires the CSB/ERCC6, CSA/
ERCC8, and UVSSA proteins11,12. Global-genome NER (GG-NER) detects 
lesions anywhere in the genome by the concerted action of the damage 
sensor protein complexes UV-DDB, comprised of DDB1 and DDB2, and 
XPC-RAD23B-CETN213. XPC and CSB are essential for the subsequent 
recruitment of the core NER factors to damaged DNA, starting with the 
transcription factor IIH (TFIIH)12,14, a 10-subunit complex involved in both 
transcription initiation and NER15. In NER, the XPB/ERCC3 ATPase and 
the structural component p62/GTF2H1 of the TFIIH complex are thought 
to anchor the complex to chromatin, via an interaction with XPC14,16,17, 
while the XPD/ERCC2 helicase is believed to unwind DNA and verify the 
presence of proper NER substrates18. Subsequent recruitment of XPA and 
RPA stimulates damage verification and facilitates the recruitment and 
correct positioning of the endonucleases XPF/ERCC4-ERCC1 and XPG/
ERCC5, which excise the damaged strand19. After excision, the resulting 
single-stranded 22-30 nucleotide DNA gap is restored by DNA synthesis 
and ligation11.
In vitro, NER is more efficient on naked DNA templates than on 
chromatinized DNA20, on which it was found to be stimulated by yeast 
SWI/SNF21, suggesting that chromatin remodeling is necessary to facilitate 
access to damaged DNA and efficient repair of lesions 8,9,20. Using SWI/SNF 
mutant C. elegans, we found that SWI/SNF proteins protect organisms 
against UV irradiation, implying a role for SWI/SNF in promoting NER in 
vivo as well22. Several additional studies in yeast and mammals further 
indicate that SWI/SNF proteins are important for the UV-induced DDR23–27. 
However, conflicting observations on whether SWI/SNF regulates damage 
detection or facilitates later repair steps have made it difficult to deduce 
the exact mechanism underlying SWI/SNF activity in NER. Furthermore, 
the majority of studies have focused on the role of the BRG1 ATPase or 
the SNF5 subunit, but a putative role for BRM has never been investigated 
in detail. 
In this study, we show that both BRM and BRG1 are necessary for efficient 
NER by promoting the expression of TFIIH subunit GTF2H1. Furthermore, 
we find that cells with permanent BRM or BRG1 loss have the ability to 
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restore GTF2H1 levels. As a consequence, DNA damage sensitivity of 
BRM- or BRG1-deficient cells correlates with GTF2H1 protein levels, which 
could, potentially, be used to select SWI/SNF-deficient cancers that are 
more sensitive to platinum drug chemotherapy.
Results
SWI/SNF is required for efficient NER 
To test for SWI/SNF involvement in GG-NER, we measured UV-induced 
unscheduled DNA synthesis (UDS) in C5RO primary fibroblasts depleted 
of BRM or BRG1 by siRNA. BRM and BRG1 knockdown cells showed a clear 
decrease in UDS, comparable to cells in which the core NER factor XPA 
was depleted (Fig. 1a,b; Supplementary Fig. 1a). In addition, we measured 
Recovery of RNA Synthesis (RRS) after UV-C irradiation in U2OS cells 
depleted of SWI/SNF, to test involvement in TC-NER. After irradiation, 
transcription levels in cells with BRM or BRG1 knockdown failed to recover 
to the same degree as in control cells (Fig. 1c,d; Supplementary Fig. 1b). 
These results indicate that both BRM and BRG1 are essential for a robust 
GG- and TC-NER activity after UV irradiation.
To date, most efforts to study SWI/SNF function in NER have focused 
on BRG1, which prompted us to direct our efforts to BRM and to 
determine in which NER step this SWI/SNF ATPase plays a role. We used 
immunofluorescence (IF) to monitor the recruitment of endogenous 
key NER proteins to local UV-C damage (LUD) - induced by irradiation 
through a microporous membrane-, 30 min after damage induction in 
siBRM treated U2OS cells. Recruitment of the early DNA damage sensors 
DDB2 and XPC to LUD, marked by CPD staining, was unaffected by BRM 
depletion (Fig. 1e,f, Supplementary Fig. 1c).  We validated these results by 
real-time confocal imaging of XPC-GFP recruitment to LUD induced by 
a 266 nm microbeam laser, which confirmed that XPC assembly kinetics 
were unchanged after BRM depletion (Supplementary Fig. 1d). Also, 
recruitment of CSB, which is difficult to assess using IF, to microbeam 
LUD was unaffected by BRM depletion (Supplementary Fig. 1e). Strikingly, 
however, BRM depletion significantly reduced the recruitment to LUD of 
the TFIIH proteins XPB, XPD and GTF2H1 and downstream proteins XPA 
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and XPF, as measured by IF (Fig. 1e,f). These results show that BRM does 
not facilitate lesion detection in GG- and TC-NER but is required for the 
recruitment of the downstream NER damage verification and excision 
machinery, thus explaining why NER is compromised in its absence.
BRM is required for the recruitment of TFIIH to chromatin
To dissect how BRM depletion impairs NER, we focused on the TFIIH 
complex and measured real-time XPB-GFP accumulation at 266 nm laser 
induced LUD, which was significantly lower (more than 2 fold) after BRM 
knockdown (Fig. 2a,b, Supplementary Fig. 1f). We confirmed this result 
with an additional independent siRNA (siBRM#2) to exclude siRNA off-
target effects (Supplementary Fig. 1g). Using Fluorescence Recovery 
After Photobleaching (FRAP), we also measured UV-induced XPB-GFP 
immobilization. As previously observed28, a fraction of XPB immobilized 
in response to UV-C irradiation in control conditions, as a result of TFIIH 
binding to UV-damaged DNA  (Supplementary Fig.1h). However, this UV-
induced XPB immobilization was substantially reduced when BRM was 
depleted by siRNA (Supplementary Fig. 1h and quantified in Fig. 2c). These 
results further corroborate our IF experiments (Fig. 1e,f) and suggest that 
BRM is needed for efficient damage loading of TFIIH.
We also assessed damage-induced chromatin loading of TFIIH in U2OS 
cells with cellular fractionation, which confirmed that UV-induced loading 
of TFIIH subunits XPB and XPD, but not of XPC, was strongly reduced 
after BRM depletion (Fig. 2d,e). Strikingly, even in the absence of DNA 
damage, TFIIH association with chromatin was reduced, whereas its non-
chromatin bound pool did not change significantly after BRM knockdown 
(Supplementary Fig. 2a). This implies that TFIIH is unable to efficiently 
interact with DNA irrespective of whether there is DNA damage or not. In 
addition, we noticed that association of BRM itself with chromatin did not 
change after DNA damage (Fig. 2d). We also could not detect recruitment 
of BRM to LUD inflicted by irradiation through a microporous membrane 
on IF (Supplementary Fig. 2b) and did not observe recruitment of GFP-
tagged BRM to LUD inflicted by 266 nm microbeam laser, as analyzed by 
real-time confocal imaging (Supplementary Fig. 2c). These results suggest 
that BRM is not actively recruited to sites of UV damage. Moreover, 
immunoprecipitation of XPB-GFP did not reveal an interaction of TFIIH 
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Figure 1. SWI/SNF is required for efficient NER. (a) Quantification of Unscheduled DNA Synthesis 
(UDS) in C5RO primary fibroblasts treated with non-targeting control (CTRL), XPA, BRM and BRG1 siRNAs 
(Supplementary Fig. 1a). UDS was determined by EdU incorporation for 1 h after UV-C (16 J/m2) irradiation 
followed by fluorescent staining of the incorporated EdU. Fluorescence was quantified and normalized to 
control, set to 100%. Mean & S.E.M. of >200 cells per sample from two independent experiments. **P< 
0.01, ***P< 0.001, relative to siCTRL. (b) UDS representative pictures, 1 h after UV-C. Scale bar: 25 µm. (c) 
Quantification of Recovery of RNA Synthesis (RRS) in U2OS cells treated with non-targeting control (CTRL), 
XPA, BRM and BRG1 siRNAs (Supplementary Fig. 1b). Transcription levels in non-irradiated cells and in cells 
2 and 20 h after UV-C irradiation (6 J/m2) were determined by a 2 h pulse-labeling with the uridine analogue 
EU and subsequent fluorescent staining and measurement of incorporated EU. RRS levels were normalized to 
non-irradiated cells, set to 100%. Mean and S.E.M. of >200 cells per condition from at least two independent 
experiments. * P< 0.05, *** P< 0.001, relative to each siCTRL in each time point. (d) RRS representative 
pictures, 20 h after UV-C irradiation. Scale bar: 25 µm. (e) Immunofluorescence (IF) showing recruitment of 
the indicated NER proteins (green channel) to local UV-C damage (LUD) in U2OS cells treated with control 
or BRM siRNAs (Supplementary Fig. 1c). Cells were fixed 30 min after inducing LUD with UV-C irradiation 
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with BRM, neither in the presence nor absence of UV-DNA damage 
(Supplementary Fig. 2d), while GTF2H1 was successfully co-purified 
with XPB-GFP, as expected. These observations indicate that BRM is not 
associated with TFIIH nor directly involved in its recruitment to chromatin, 
but suggest that BRM affects TFIIH chromatin binding in another way, 
possibly by regulating its general activity, stability or expression of its 
subunits. 
BRM stabilizes TFIIH by promoting GTF2H1 expression
The TFIIH complex consists of 10 subunits and becomes unstable if one of 
these is impaired15,29–31. Given the fact that SWI/SNF acts in transcription 
regulation, we considered the possibility that BRM transcriptionally 
regulates one or more TFIIH genes. Therefore, we analyzed the individual 
expression of all TFIIH genes by real-time-qPCR (RT-qPCR) in U2OS 
cells after BRM knockdown. While expression of most TFIIH genes was 
unaffected by BRM knockdown, GTF2H1 expression was strongly reduced 
(Fig. 3a). Immunoblot analysis revealed that this also resulted in lowered 
GTF2H1 protein levels (Fig. 3b), which we further corroborated by IF 
staining of GTF2H1 after BRM depletion using an independent siRNA 
(siBRM#2), to exclude siRNA off-target effects (Supplementary Fig. 3a,b). 
Besides GTF2H1, we also found mildly reduced expression of XPB, both 
at the mRNA and protein level. In contrast, protein levels of XPD and 
CCNH - whose mRNA levels were mildly increased -, and of TFIIEβ, XPC 
and DDB2 were unaltered after BRM depletion (Fig. 3a,b). To verify that 
BRM can regulate GTF2H1 transcriptionally, we re-analyzed published 
whole-genome BRM ChIP-seq data for HepG232 and RWPE133 cells. In 
both cell types we observed an enrichment of BRM ChIP-seq signal at the 
GTF2H1 promoter region, suggesting the association of BRM with active 
regulatory regions of the GTF2H1 gene (Fig. 3c, Supplementary Fig. 3c). 
These results therefore suggest that BRM promotes GTF2H1 expression 
and may explain why BRM depletion leads to defects in TFIIH chromatin 
loading, as GTF2H1 was shown to be essential for the structural integrity 
(60 J/m2) through a microporous membrane (8 µm). UV lesions were marked with staining against CPD or 
XPC, red channel. DNA was stained with DAPI. Scale bar: 5 µm. (f) Quantification of NER proteins recruitment 
to LUD. Relative accumulation at LUD (over nuclear background) after siBRM was normalized to control, in 
which nuclear background was set at 0 and maximal signal at LUD set to 1.0 for each protein. Mean and 
S.E.M. of >100 cells per sample, of at least two independent experiments, except for GTF2H1 which was only 
performed once. ** P< 0.01, relative to siCTRL. n.s., non-significant. 
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of the TFIIH complex31. 
To assess whether TFIIH indeed becomes unstable in the absence of BRM, we 
determined the half-life of XPB in BRM-depleted U2OS cells after blocking 
protein synthesis with cycloheximide (CHX) treatment. Quantification of 
XPB protein levels, normalized to DDB2, revealed a strongly accelerated 
proteasome-dependent degradation of XPB in the absence of BRM (Fig. 
3d,e; Supplementary Fig. 3d). Importantly, XPB was similarly less stable 
in cells depleted of GTF2H1 by siRNA (Fig. 3d,e). To confirm that BRM 
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Figure 2. BRM is required for the recruitment of TFIIH to chromatin. (a) Real-time imaging of XPB-
GFP accumulation at 266 nm UV-C laser-induced LUD in XPCS2BA cells treated with control and BRM 
siRNA (siCTRL and siBRM, respectively; Supplementary Fig. 1f). Pre-damage fluorescence intensity (nuclear 
background) was set to 100% (t=0). Mean & S.E.M. of three independent experiments each with more than 
10 cells per condition. P< 0.0001, compared to siCTRL. (b) Representative images of real-time recruitment 
of XPB-GFP, which resides exclusively in the nucleus, to laser generated LUD. Arrows indicate LUD regions. 
(c) Quantification of XPB-GFP immobile fraction in XPCS2BA fibroblasts. The mobility of XPB-GFP was 
determined by Fluorescence Recovery After Photobleaching (FRAP) in mock and UV-C irradiated (10 J/m2) 
cells treated with non-targeting control (CTRL) or BRM siRNAs, as depicted in Supplementary Fig. 1h. The 
UV-induced immobile fraction (mean & S.E.M. from three independent experiments, with at least 10 cells 
measured per condition each time) was determined as described in Supplementary Fig. 1h. *** P< 0.001 
relative to UV-irradiated siCTRL. (d) Immunostaining of soluble (nucleoplasm) and chromatin-bound XPB, 
XPD, XPC, BRM and H1.2 (as loading control) in U2OS cells treated with non-targeting control (CTRL) or BRM 
siRNAs. Cells were collected for protein fractionation at different time points after UV-C irradiation (20 J/m2). 
(e) Relative quantification of chromatin-bound XPB and XPD, normalized to non-irradiated siCTRL, set to 1.0. 
Mean & S.E.M. of two independent experiments. Full-size immunoblot scans are provided in Supplementary 
Fig. 6a.
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Figure 3. BRM stabilizes TFIIH by promoting GTF2H1 expression. (a) Relative quantification of individual 
TFIIH genes expression in U2OS cells treated with control (CTRL) or BRM siRNAs, as determined with RT-
qPCR. Individual basal gene expression in BRM knockdown was normalized to siCTRL levels, which were set 
to 1.0 (dotted line in graph). GAPDH expression was used for normalization. Mean & S.E.M. of at least three 
independent experiments. ** P< 0.01, *** P< 0.001 relative expression in each gene to siCTRL. n.s., non-
significant. (b) Immunoblot analysis of TFIIH protein levels (GTF2H1, XPB, XPD, CCNH), TFIIEβ, DDB2 and XPC 
from whole cell extracts of U2OS treated with control (CTRL) or BRM siRNAs. Representative immunoblots 
of two independent experiments. (c) BRG1 and BRM co-occupancy of GTF2H1 promotor. Re-analysis of 
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depletion specifically affected TFIIH and not other transcription factors as 
well (whose DNA-binding might be regulated by BRM5,34), we tested the 
stability of subunit beta of transcription initiation factor IIE (TFIIEβ). TFIIEβ 
is involved in recruiting TFIIH to the transcription initiation complex35, but 
its stability was not affected by BRM knockdown (Fig. 3d, Supplementary 
Fig. 3e). These results, therefore, suggest that the TFIIH complex is less 
stable in the absence of BRM because of reduced amounts of GTF2H1 that 
limit the stable assembly of functional TFIIH complexes. This likely impairs 
the stability of TFIIH subunits and TFIIH function in transcription and NER. 
Indeed, either BRM or GTF2H1 depletion also reduced transcription levels 
in U2OS cells, likely due to limiting amounts of TFIIH (Fig. 3f). 
GTF2H1 expression rescues TFIIH function in BRM/BRG1 
depleted cells 
To demonstrate that impaired TFIIH function in BRM knockdown cells is 
mainly a consequence of GTF2H1 downregulation, we tested if ectopic 
expression of GFP-GTF2H1 or XPB-GFP (as control) reversed impaired 
TFIIH DNA damage recruitment. Overexpression of both TFIIH subunits 
did not affect XPD recruitment to LUD in control U2OS cells (Fig. 4a,b). 
However, overexpression of GFP-GTF2H1, but not of XPB-GFP, rescued 
XPD accumulation to LUD in BRM and GTF2H1 depleted cells, confirming 
that reduced GTF2H1 expression, as a consequence of BRM depletion, 
impairs TFIIH function. 
Since BRG1 depletion also resulted in GG- and TC-NER defects (Fig. 1a-
d), similar to BRM, we tested whether BRG1 knockdown also affected 
published ChIP-seq data in which ChIP-seq signal density (top) and respective peaks (bottom) illustrate BRG1 
(purple) and BRM (green) enrichment at the promoter of GTF2H1 in HepG2 cells (upon shNS transfection32). 
Promoter region of interest highlighted in light orange, signal density in reads per million. (d) XPB protein 
stability was evaluated in U2OS cells treated with control (CTRL) or BRM siRNAs at different time points after 
addition of 100 µM cycloheximide (CHX) to inhibit protein synthesis. Immunostainings of TFIIEβ and DDB2 
were used as negative and loading controls, respectively. (e) Quantification of XPB protein levels normalized 
to DDB2 in time after addition of CHX. The total amount of XPB in whole cell lysates was set to 1.0 at t=0. 
Mean & S.E.M. of at least three independent experiments. * P< 0.05, ** P< 0.01, *** P< 0.001 for each time 
point of siBRM (green) or siGTF2H1 (orange) relative to siCTRL. (f) Relative quantification of transcription 
levels in U2OS cells treated with non-targeting control (CTRL), BRM, BRG1 or GTF2H1 siRNAs. Transcription 
was determined by measuring EU incorporation in non-irradiated cells 48 h after siRNA treatment. EU 
relative fluorescence intensity was set to 100% in siCTRL treated cells. Mean & S.E.M. of >200 cells from two 
(siGT2H1) and three (siBRM and siBRG1) independent experiments. Full-size immunoblot scans are provided 
in Supplementary Fig. 6b,c.
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TFIIH function via GTF2H1. Depletion of BRG1 led to lower overall 
transcription (Fig. 3f) and reduced GTF2H1 protein levels, as assessed 
by both immunoblot (Supplementary Fig. 3f) and IF using independent 
siRNAs to exclude off-target effects (Supplementary Fig. 3g,h). BRG1 was 
furthermore found to co-occupy the GTF2H1 promoter together with 
BRM (Fig. 3c, Supplementary Fig. 3c). Also, BRG1 depletion led to reduced 
XPD recruitment to LUD (Supplementary Fig. 3i), which was rescued by 
ectopic expression of GTF2H1, but not of XPB (Fig. 4b,c). BRG1 did not 
localize to LUD induced by irradiation through a microporous membrane 
(Supplementary Fig. 2b) or by 266 nm microbeam laser (Supplementary 
Fig. 2c), implying that the protein itself does not directly participate in the 
NER reaction. Moreover, both siBRM and siBRG1 did not alter cell cycle 
distribution (Supplementary Fig. 3j) nor did they further decrease reduced 
XPD recruitment following GTF2H1 depletion (Supplementary Fig. 3k), 
indicating that BRM and BRG1 do not impair TFIIH recruitment due to 
indirect effects on the cell cycle or independently of GTF2H1. Overall, 
these results indicate that the activity of both BRM and BRG1 is necessary 
to ensure normal GTF2H1 levels and TFIIH function, and, therefore, NER 
performance. 
Chronic BRG1-deficient cancer cells restore GTF2H1 
Because BRM and BRG1 are frequently mutated in cancer3, we investigated 
if cancer cell lines with SWI/SNF mutations showed low GTF2H1 protein 
levels, as these cells would then likely be more susceptible to DNA 
damaging chemotherapeutic drugs. Unexpectedly, BRG1-deficient non-
small cell lung cancer (NSCLC) lines A549 and H129936–38 showed normal 
GTF2H1 levels in comparison to U2OS (Fig. 5a,b). Strikingly, however, BRM 
knockdown in these NSCLC cell lines resulted in lower GTF2H1 expression, 
demonstrating that SWI/SNF-mediated expression of GTF2H1 is not cell 
type-specific. BRG1 knockdown only resulted in lower GTF2H1 levels in 
U2OS cells, which are wild-type for BRG1, but not in the BRG1-deficient 
A549 and H1299 cell lines (Fig. 5a,b), confirming again that GTF2H1 
downregulation in U2OS cells is not due to an siRNA-mediated off-target 
effect. We next tested GTF2H1 protein levels by IF in additional BRG1 and/
or BRM deficient cancer cell lines. However, also BRG1-deficient Panc-1 and 
Hs 700T cells, BRM deficient A2780 cells and BRM/BRG1-deficient SW13 
and C33A cells, all consistently showed normal or even increased GTF2H1 
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levels, as compared to MRC5, Hs 578T and U2OS cells (Supplementary 
Fig. 4a,b). The puzzling finding that chronic BRG1 and/or BRM deficiency 
in these cancer cell lines does not lead to permanent downregulation of 
GTF2H1, whereas transient depletion does, indicates that there might be 
an adaptive, compensatory mechanism in these cells that restores GTF2H1 
expression to prevent chronic TFIIH dysfunction. 
BRM and BRG1 have been shown to be able to compensate for some of 
each other’s functions36,39 and in many BRG1-deficient cancer cells including 
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Figure 4. GTF2H1 expression rescues TFIIH in BRM/BRG1 depleted cells. Representative IF of XPD 
recruitment (red channel) to LUD marked by XPC (cyan channel). U2OS cells were fixed 30 min after local 
UV-C irradiation (60 J/m2) through a microporous membrane (8 µm). (a) U2OS cells were treated with control 
(CTRL), BRM or GTF2H1 siRNAs and transiently transfected with TFIIH subunits XPB or GTF2H1 fused to 
GFP (green channel). Scale bar: 10 µm. (b) Quantification of XPD recruitment to LUD. Relative accumulation 
at LUD (over nuclear background) in each condition was normalized to control (siCTRL without transient 
transfection of TFIIH subunits, indicated by “empty“ symbol), in which nuclear background was set at 0 and 
maximal signal at LUD set to 1.0 (> 50 cells per sample, mean & S.E.M. from four independent experiments). 
*** P< 0.001, relative to siCTRL without transient transfection of TFIIH subunits. (c) U2OS cells were treated 
with siRNA against BRG1 and transiently transfected with TFIIH subunits XPB or GTF2H1 fused to GFP (green 
channel). Scale bar: 10 µm. Arrows highlight LUD in a mixed population of non-transfected and transfected 
cells with GFP-GTF2H1 or XPB-GFP (green cells in the right panel). n.s., non-significant. 
543301-L-sub01-bw-Silva
Processed on: 6-5-2020 PDF page: 46
Chapter 2
46
c
a
U2OS
+      
-  
-    
-      
+
-      
-      
-
+      
siCTRL
siBRM  
siBRG1#2    
BRG1
BRM
GTF2H1
Ku70
kDa
250
A549
+      
-  
-    
-      
+
-      
-      
-
+      
H1299
+      
-  
-    
-      
+
-      
-      
-
+      
250
75
50
e
siBRM
siBRG1#2
A549 A549
+GFP-GTF2H1
20
0
40
60
80
100
120
C
ol
on
y 
fo
rm
at
io
n 
ca
pa
ci
ty
 %
20
0
40
60
80
100
120
C
ol
on
y 
fo
rm
at
io
n 
ca
pa
ci
ty
 %
siCTRL
siBRM
siBRG1#2
siCTRL
***
******
***
n.s. n.s.
n.s.
H1299 H1299 
+GFP-GTF2H1
b
siBRMsiCTRL siBRG1#2
R
el
at
iv
e 
G
TF
2H
1 
le
ve
ls
0
0.4
1.0
1.4
0.6
0.2
1.2
0.8
U2OS A549 H1299
***
**
n.s.
n.s.
n.s.
n.s.
***
**
-
+ 
-
-    
-      
-
+
-      
-      
-
-
+      
GFP-GTF2H1
siCTRL
siBRM
siBRG1#2
BRG1
BRM
Ku70
kDa
250
A549
+      
+ 
-
-    
+
- 
+
-     
+
-
-
+      
250
75
50
GFP-GTF2H1
Endogenous 
GTF2H1
d
siCTRL
siBRM
siBRG1#2
A549 A549 + GFP-GTF2H1
Figure 5. Cancer cells with chronic BRG1 deficiency restore GTF2H1 expression. (a) Immunoblot showing 
total protein levels of BRM, BRG1 and GTF2H1, in cell lysates of U2OS and BRG1-deficient non-small lung 
cancer cell (NSCLC) lines A549 and H1299 treated with control (CTRL), BRG1 or BRM siRNAs. Ku70 was 
used as loading control. (b) Relative quantification of GTF2H1 protein levels in U2OS, A549 and H1299 cells 
transfected with control (CTRL), BRG1 or BRM siRNA. GTF2H1 levels were normalized to Ku70 and the total 
relative amount of GTF2H1 in whole cell lysates was set to 1.0 in U2OS siCTRL. Mean & S.E.M. from at least 
three independent experiments ** P< 0.01, *** P< 0.001, n.s., non-significant. (c) A549 cells with and without 
stable expression of GFP-GTF2H1, driven by the ectopic PGK promoter, were treated with control (CTRL), 
BRM or BRG1 siRNAs. Cell lysates were analyzed by immunoblotting against BRM and GTF2H1. Ku70 was 
used as loading control. (d) A549 cells, with or without stable expression of GFP-GTF2H1 were seeded 48 h 
after transfection with control (CTRL), BRM or BRG1 siRNAs, in triplicate, at a density of 1000 cells per well 
and grown for 12 before fixation and staining. (e) Quantification of colony forming capacity of A549  (shown 
in d) and H1299 (shown in Supplementary Fig. 4e) cell lines with or without stable GFP-GTF2H1 expression 
and treated with control (CTRL), BRM or BRG1 siRNAs. Clonal capacity was normalized to 100% in control 
conditions (CTRL). Mean & S.E.M. of three independent experiments, each performed in triplicate. *** P< 
0.001, n.s., non-significant, relative to siCTRL. Full-size immunoblot scans are provided in Supplementary 
Fig. 7a,b.
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A549 and H1299, BRM has even become essential for cellular growth36,38,40. 
To test if regulation of GTF2H1 levels are in part responsible for BRM 
having become essential in BRG1-deficient cells, we generated A549 and 
H1299 cell lines stably expressing GFP-GTF2H1 (Fig. 5c, Supplementary 
Fig. 4c). siRNA-mediated BRM knockdown in these cells only reduced 
the expression of endogenous GTF2H1 (Fig. 5c, Supplementary Fig. 4c,d), 
guaranteeing that expression of the GFP-GTF2H1 transgene, driven by the 
ectopic PGK promoter, is preserved even in the absence of both SWI/
SNF ATPases. We then performed colony forming assays and found that 
siRNA-mediated depletion of BRM led to profound growth inhibition of 
BRG1-deficient A549 and H1299 cells. This, however, was not rescued 
by stable GFP-GTF2H1 expression (Fig. 5c-e, Supplementary Fig. 4e). As 
expected, control and BRG1 siRNA did not affect the proliferation capacity 
of these BRG1 deficient cells. These results indicate that synthetic lethality 
induced by BRM depletion in BRG1-deficient cancer cells is not dependent 
on GTF2H1 expression and likely involves other functions of these ATPases. 
DNA damage sensitivity of BRM cells correlates with GTF2H1 
levels 
To confirm that cells can restore GTF2H1 expression as adaptation to chronic 
SWI/SNF dysfunction and to investigate the functional consequences, 
we permanently knocked out BRM and BRG1 in immortalized MRC5 
fibroblasts, by transfection with sgRNAs targeting either BRM (sgBRM) or 
BRG1 (sgBRG1). After careful selection of transfected cells, we confirmed by 
immunoblotting that this heterogeneous pool of transfected cells showed 
an overall highly efficient depletion of BRM or BRG1 and a concomitant 
downregulation of GTF2H1 levels (Fig. 6a,b). However, after culturing cells 
for multiple passages, IF of the heterogeneous pool of BRM and BRG1 
knockout cells revealed that individual cells had either retained the low 
GTF2H1 expression or restored it to wild-type level (Supplementary Fig. 
5a). Establishment of multiple clonal cell lines from the MRC5 sgBRM pool 
of cells showed that many clones exhibited normal GTF2H1 levels, despite 
having no detectable BRM expression (Supplementary Fig. 5b). These 
striking findings show that cells are often able to adapt to the loss of one 
of the ATPase SWI/SNF subunits by restoring normal GTF2H1 expression 
levels. 
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Figure 6. DNA damage sensitivity of BRM deficient cells correlates with GTF2H1 expression. (a) 
Immunoblot of BRM, BRG1 and GTF2H1 in MRC5 wild-type (WT) cells and cells transfected with sgRNA 
against BRM or BRG1. (b) Quantification of GTF2H1 levels in immunoblot shown in (a), corrected by Tubulin 
loading control, and set to 1.0 in MRC5 WT. (c) IF of total GTF2H1 and BRM levels in MRC5 WT and sgBRM 
knockout clones c1, c3, c6 and c7. Scale bar: 10 μm. (d) Quantification of GTF2H1 IF signal (shown in c). Total 
GTF2H1 levels were normalized to MRC5 WT, set to 1.0. Mean & S.E.M. of >200 cells from two independent 
experiments (e) Immunoblot of BRM, BRG1 and GTF2H1 levels in MRC5 WT and sgBRM clones c1, c3, c6 
and c7. (f) Quantification of GTF2H1 levels shown in (e), as described in (b), using Ku70 as loading control. 
Mean & S.E.M. from four independent experiments. (g) GTF2H1 levels in a mixed population of MRC5 sgBRM 
knockout clone c1 cells non-transfected or transfected with BRM-GFP or BRG1-GFP. Scale bar: 5 μm. (h) XPD 
recruitment to LUD in MRC5 WT and sgBRM knockout clones c1 and c3, 30 min after damage. Scale bar: 5 
μm. (i) Relative quantification of XPD recruitment to LUD (shown in h) in MRC5 WT and sgBRM knockout 
clones c1 and c3, normalized to WT, as described in the methods. Mean & S.E.M. of >65 cells per sample. 
(j) UV-C colony survival of MRC5 WT cells and sgBRM knockout clones c1 and c3.  (k) Cisplatin colony 
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We next selected two clones with low (c1 and c6) and two clones with 
normal (c3 and c7) GTF2H1 expression and confirmed the reduced and 
rescued GTF2H1 levels and BRM knockout by IF and immunoblot (Fig. 6c-
f) and by sequencing the sgBRM target region (Supplementary Fig. 5c). 
Transient expression of BRM-GFP in c1 cells increased GTF2H1 expression 
(Fig. 6g), clearly demonstrating not only that the lower GTF2H1 levels are 
caused by BRM depletion but also that these are reversible. Transient 
BRG1-GFP expression, however, did not increase GTF2H1 protein levels 
in these cells (Fig. 6g). Likewise, stable ectopic expression of GFP-tagged 
BRG1 in U2OS cells did not prevent the reduction in GTF2H1 levels after 
siBRM treatment (Supplementary Fig. 5d). These results suggest that 
restoration of GTF2H1 levels, as observed in cells with chronic BRM/BRG1 
deficiency, is likely not due to compensation by the other ATPase. 
Due to the central function of TFIIH in NER, we considered whether 
GTF2H1 levels in BRM knockout cells correlate with NER capacity and thus 
with sensitivity to DNA damaging agents. XPD recruitment to LUD was 
severely impaired in c1 cells with low GTF2H1 levels, but not in c3 cells with 
normal GTF2H1 levels (Fig. 6h,i). Clonal UV-survival assays corroborated 
these observations, showing that only c1 cells were UV-hypersensitive 
(Fig. 6j). These intriguing results could imply that cancer cells that have 
lost the activity of SWI/SNF subunit(s) may be differentially sensitive to 
DNA damaging chemotherapeutics depending on their GTF2H1 levels. 
Platinum-based drugs such as cisplatin are widely administered to treat 
various types of solid tumors41 and kill cells by inducing DNA intra- and 
interstrand crosslinks that are mainly repaired by NER42 and interstrand 
crosslink repair. Therefore, we tested cisplatin sensitivity of c1 and c3 
cells to evaluate if this also correlates with their GTF2H1 expression 
levels. Markedly, c1 cells, but not c3 cells, showed increased sensitivity to 
cisplatin (Fig. 6k). To verify these findings, we also tested DNA damage 
sensitivity of BRM knockout clones c6 and c7, exhibiting respectively low 
and restored GTF2H1 levels (Fig. 6c-f). UV and cisplatin survival of these 
survival of MRC5 WT and BRM knockout clones c1 and c3.  (l) UV-C colony survival of MRC5 WT cells and 
BRM knockout clones c6 and c7. (m) Cisplatin colony survival of MRC5 WT cells and BRM knockout clones 
c6 and c7. Colony number was normalized to untreated conditions. Mean & S.E.M. of four (UV-survival) 
and two (cisplatin-survival) independent experiments, each performed in triplicate, are presented. *P< 0.05, 
** P< 0.01, *** P< 0.001, relative to WT, n.s., non-significant. Full-size immunoblot scans are provided in 
Supplementary Fig. 7c,d.
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clones (Fig. 6l,m) confirmed that indeed GTF2H1 levels in BRM knockout 
cells determine NER capacity and sensitivity to DNA damage. These 
results indicate that loss of BRM sensitizes cells to cisplatin only if GTF2H1 
protein levels are lowered, and imply that GTF2H1 levels could be used 
as a predictive marker for platinum drug sensitivity of SWI/SNF-deficient 
cancers. 
Discussion
Inactivating mutations in SWI/SNF subunit genes are amongst the most 
recurrent mutations found in all human cancers3,4. For instance, BRG1 is 
mutated in 90% of small cell ovarian, 27% of skin and 5% of small cell lung 
cancers1,7,37. The homologous SWI/SNF ATPase BRM is also recurrently lost 
in multiple primary tumors and cancer cell lines, such as in over 15% of 
lung, ovarian and breast cancers43 and was found to protect mice against 
UV-induced skin cancer44. It is thus advantageous to identify general 
vulnerabilities caused by SWI/SNF deficiency in pathways with anti-
tumorigenic function, to create opportunities for the development of 
effective therapeutic approaches. 
In this study, we show that both BRM and BRG1 promote normal TFIIH 
function in transcription and NER by regulating the expression of the 
GTF2H1 gene (Fig. 7). Both RT-qPCR and immunoblot analysis revealed 
significantly lower expression of GTF2H1 and mildly lower expression of 
XPB after BRM knockdown. Both these TFIIH subunits are required for 
recruitment of the TFIIH complex to damaged DNA14,16, but only the 
ectopic expression of GTF2H1 - not of XPB - rescued the binding of TFIIH 
to DNA damage in BRM and BRG1 depleted cells. This shows that lowered 
levels of GTF2H1, caused by BRM or BRG1 knockdown, act as a limiting 
factor for the assembly of functional TFIIH complexes, in agreement with 
recent literature describing GTF2H1 as essential for TFIIH complex integrity 
and stability31,45. Limiting amounts of functional TFIIH complexes likely 
impair overall TFIIH functions, in accordance with the observed decreased 
transcription levels and lower NER performance (Fig. 7). 
ATP-dependent chromatin remodelers like SWI/SNF are thought to make 
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chromatin more accessible to DNA repair proteins8,9,20. In line with this idea, 
the yeast Snf5 and Snf6 SWI/SNF subunits were shown to bind XPC and 
mediate UV-induced nucleosome remodeling23, while in humans BRG1 
was reported to facilitate XPC recruitment to damaged DNA25. However, 
in another study, a different role for human BRG1 in NER was proposed, 
in facilitating XPG and PCNA - but not DDB2 and XPC - recruitment to 
sites of damaged DNA24. Our data, indeed, shows that both BRG1 and 
BRM are essential for efficient recruitment of late NER factors (TFIIH 
Stable and functional 
TFIIH complexes
SWI/SNF complexes
BRM/BRG1 deficiencyNormal SWI/SNF activity
Limiting TFIIH
Compensation mechanism
Potential therapeutic target
Normal Deficient
?
+ -
Normal expression Lower expression
Marker for
hypersensitive SWI/SNF 
cancers
Increased sensitivity to 
 DNA damaging agents 
UV, platinum drugs
BRM/BRG1
GTF2H1 GTF2H1
DNA repair (NER)
Transcription
Figure 7. Low GTF2H1 expression as a predictive marker for DNA damage hypersensitive SWI/SNF 
cancers. BRM- and BRG1-containing SWI/SNF complexes promote the expression of the GTF2H1 gene, 
a subunit of the TFIIH complex. In BRM- and BRG1-wild-type cells, normal expression of GTF2H1 allows 
the assembly of stable and functional TFIIH complexes, proficient in transcription and NER. When BRM or 
BRG1 are deficient, expression of GTF2H1 is lower, limiting the assembly of functional TFIIH complexes. As 
a consequence, transcription levels and NER capacity are lower, and cells become more sensitive to DNA 
damaging agents like UV and chemotherapeutic platinum drugs. Therefore, low GTF2H1 levels can likely 
be used as a marker to identify SWI/SNF cancers with increased sensitivity to chemotherapeutic drugs. 
However, cells with permanent loss of either BRM or BRG1 subunit can also adapt and restore the expression 
of GTF2H1, thus presenting normal transcription and NER activity. The mechanism underlying this adaption 
response is currently unknown, but if elucidated could be therapeutically exploited to specifically target SWI/
SNF cancers with restored GTF2H1 expression, leaving surrounding non-tumor tissues intact. 
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and downstream NER proteins) rather than for binding of the early DNA 
damage sensing factors (XPC, DDB2, and CSB) to DNA lesions. Impaired 
recruitment of the late NER factors in the absence of SWI/SNF is, however, 
not caused by reduced chromatin accessibility, but an indirect result of 
limiting amounts of functional TFIIH. Furthermore, we did not observe 
BRM and BRG1 recruitment to UV-damaged DNA, further corroborating 
that SWI/SNF’s main involvement in the UV-DDR is not in the control of 
chromatin accessibility at sites of UV damage. 
SWI/SNF complexes are thought to be recruited to chromatin to 
remodel nucleosomes in enhancer and promoter regions to regulate 
transcription7,46. In line with this, we observed in two different cell types 
that BRM and BRG1 ChIP-seq signals are enriched at the GTF2H1 promoter. 
SWI/SNF’s influence on gene expression is, however, contextual, in that it 
represses some promoters while it stimulates others5, which may also be 
evident from the differential effect of BRM knockdown on transcription 
of TFIIH genes that we observed. One major way through which SWI/
SNF promotes transcription is by antagonizing the repressive activity of 
Polycomb complexes, as loss of SWI/SNF was shown to lead to repression 
of Polycomb target genes47,48. Nevertheless, we were unable to alleviate 
downregulation of GTF2H1 upon knockdown of BRM or BRG1 with 
specific inhibitors targeting EZH2, a functional enzymatic component of 
the Polycomb repressive Complex 2. This suggests that other mechanisms, 
possibly involving repressive chromatin structures or epigenetic marks, 
account for the diminished GTF2H1 expression.  
Besides NER, SWI/SNF chromatin remodeling complexes are also involved 
in other DDR pathways8,9,49, including regulation of DSB repair by non-
homologous end-joining and/or homologous recombination50,51. It is, thus, 
likely that SWI/SNF mutations found in cancer contribute to increased 
genomic instability by disrupting multiple DDR pathways. As the majority 
of BRG1-deficient tumors are negative for mutations in other genes 
that can be targeted by existing therapies40, it would be advantageous 
to exploit DDR deficiencies in SWI/SNF cancers therapeutically. Based 
on our analysis, one such DDR deficiency could be impaired NER due to 
downregulation of GTF2H1 expression, rendering SWI/SNF cancers more 
sensitive to DNA damaging chemotherapeutic drugs such as cisplatin 
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(Fig. 7). However, we observed that in multiple established BRG1 and/or 
BRM-deficient cancer cell lines, GTF2H1 levels were not lowered, which is 
probably due to an, yet unknown, adaptation mechanism to compensate 
for the loss of BRM/BRG1 activity (Fig. 7). Previous studies showed partial 
mutual compensation between both ATPases36,38,40. Nevertheless, the fact 
that normal GTF2H1 levels were observed in cells lacking both BRG1 and 
BRM and that overexpression of BRG1 did not increase GTF2H1 levels in 
BRM deficient cells suggests that BRM and BRG1 do not compensate for 
each other in regulating GTF2H1 expression. Our experiments with MRC5 
BRM knockout cell lines confirm that cells can adapt to the loss of one of 
the SWI/SNF ATPases. Although knockout of BRM led to an initial overall 
reduction in GTF2H1 levels, after prolonged culturing and clonal selection 
we observed that many clones displayed normal GTF2H1 expression. 
Importantly, cells exhibited hypersensitivity to DNA damage induction by 
UV irradiation and cisplatin treatment only when GTF2H1 levels were low.
Recently, it was suggested that BRG1 expression could be used as a 
predictive biomarker for platinum-based chemotherapy response in 
NSCLC lines52,53. However, as we here demonstrate, sensitivity of SWI/SNF-
deficient cells to DNA damaging agents such as cisplatin mainly depends 
on GTF2H1 expression levels. Therefore, reduced GTF2H1 expression may 
be a better predictive marker for platinum-drug sensitivity of SWI/SNF-
deficient cancers (Fig. 7). Moreover, given the importance of TFIIH for 
transcription and repair, elucidating the mechanisms underlying SWI/SNF 
regulation of GTF2H1 expression and those that allow cells to adapt and 
restore GTF2H1 levels will be key to develop new strategies targeting SWI/
SNF cancers. Such knowledge could potentially reveal how to revert the 
adaptation response to lower GTF2H1 levels, rendering SWI/SNF-deficient 
cells more susceptible to platinum drug chemotherapy. 
Methods
Cell lines, culture conditions and treatments. U2OS (ATCC), SV40-
immortalized human fibroblasts MRC5 (ATCC) and XP4PA54 (XPC-deficient, 
with stable expression of XPC-GFP), XPCS2BA (XPB-deficient, with stable 
expression of XPB-GFP28) and CS1AN (CSB-deficient, with stable expression 
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of GFP-CSB55) were cultured under standard conditions in a 1:1 mixture 
of DMEM (Lonza) and Ham’s F10 (Lonza) supplemented with 10% fetal 
calf serum (FCS). C5RO primary fibroblasts (established in our laboratory) 
were cultured in Ham’s F10 supplemented with 12% FCS; H1299 NSCLC 
(provided by Dr. Bert van der Horst), A549 NSCLC (provided by Dr. Suzan 
Pas), Hs 578T56 breast cancer, A278038 ovarian cancer (provided by Corine 
Beaufort and Dr. John Martens), Hs 700T36 and Panc-157 pancreatic cancer 
(provided by Dr. Bernadette van den Hoogen), SW1336 adrenal cortex 
carcinoma and C33A36 cervical carcinoma (provided by Dr. Jan van der 
Knaap) cells were cultured in a 1:1 mixture of DMEM (Lonza) and RPMI 
(Sigma) medium supplemented with 10% FCS. Stable XPC-GFP expressing 
XP4PA cells were generated using lentiviral transduction and selected 
with 0.3 µg/mL Puromycin and FACS. Stable GFP-GTF2H1 expressing cells 
(A549, H1299) were generated using lentiviral transduction and selection 
with 5-10 µg/mL Blasticidin. Stable BRM-GFP and BRG1-GFP expressing 
U2OS cells were generated using transfection and selection with 10 µg/
mL Blasticidin. All cells were cultured in medium containing 1% penicillin-
streptomycin at 37°C and 5% CO2. siRNA transfections were performed 
using RNAiMax (Invitrogen) 2 days before each experiment, according to 
the manufacturer’s instructions. Plasmids transfections were performed 
using FuGENE 6 (Promega), according to the manufacturer’s instructions. 
All cell lines were regularly tested for mycoplasma contamination. 
Plasmids, sgRNA, and siRNA. Full-length human cDNAs of GTF2H1, 
BRG1 and BRM (a kind gift from Dr. Kyle Miller58), were fused to GFP and 
inserted into pLenti-PGK-Blast-DEST59 to generate plasmids GFP-GTF2H1, 
BRG1-GFP and BRM-GFP. Full-length human XPC cDNA was fused to GFP 
and inserted into pLenti-CMV-Puro-DEST59 to generate plasmid XPC-GFP. 
For the generation of knockout cell lines, sgRNA sequences targeting 
BRM (GTCTCCAGCCCTATGTCTGG) and BRG1 (CAGCTGGTTCTGGTTAAATG) 
coding regions were cloned into pLenti-CRISPR-V160. Cloning and plasmid 
details are available upon request. siRNA oligomers were purchased 
from GE Healthcare: CTRL (D-001210-05), BRM#1 (J-017253-06), BRM#2 
(J-017253-07), BRG1 (L-010431-00), BRG1#2 (J-010431-06), BRG1#3 (J-
010431-07), GTF2H1 (L-010924-00) and XPA (MJAWM-000011). 
UV-C irradiation. UV-C irradiation was inflicted using a germicidal lamp 
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(254 nm; TUV lamp, Phillips) with the indicated doses after washing cells 
with PBS. Local damage was generated using 60 J/m2 of UV irradiation 
through an 8 µm polycarbonate filter (Millipore), as described in van Cuijk 
et al61. 
Unscheduled DNA Synthesis and Recovery of RNA Synthesis. 
Fluorescent UDS and RRS were performed as described before62. In short, 
for UDS C5RO primary fibroblasts were grown on coverslips and treated 
with siRNAs 48 h before UV-C irradiation (16 J/m2). After irradiation, cells 
were incubated for 1 h in medium containing 5-ethynyl-2’-deoxyuridine 
(EdU, Invitrogen). For RRS, U2OS cells were seeded on coverslips and 48 h 
after siRNA transfection irradiated with 6 J/m2 UV-C and allowed to recover 
for 2 or 20 h. Irradiated and non-irradiated cells were incubated for 2 h 
in medium containing 5-ethynyl-uridine (EU, Jena Biosciences). Cells were 
fixed in 4% paraformaldehyde and permeabilized with 0.1% Triton X-100 
in PBS. EdU or EU incorporation was visualized by incubating cells for 1 
h at room temperature with Click-it reaction cocktail containing Atto 594 
Azide (60 µM, Atto Tec.), Tris-HCl (50 mM, pH 7.6), CuSO4*5H2O (4mM, 
Sigma) and ascorbic acid (10 mM, Sigma). After washes in 0.1% Triton-X100 
in PBS, DNA was stained with DAPI (Sigma), and slides were mounted 
using Aqua-Poly/Mount (Polysciences, Inc.). Images were acquired using 
an LSM700 microscope equipped with a 40x Plan-apochromat 1.3 NA oil 
immersion lens (Carl Zeiss Micro Imaging Inc.). UDS and RRS levels were 
quantified by measuring the total nuclear fluorescence intensities (in at 
least 100 cells per experiment) with FIJI image analysis software. Intensity 
levels were averaged and normalized to the fluorescence levels in control 
conditions, which were set at 100%. 
Immunofluorescence. Cells were grown on coverslips, fixed in 4% 
paraformaldehyde and permeabilized in PBS containing 0.5% Triton 
X-100. DNA was denatured for 5 min with 70 mM NaOH to allow CPD 
binding by the antibody. Next, cells were incubated for 1 h with blocking 
solution 3% BSA in PBS-T (0.1% Tween 20) and subsequently incubated 
with antibodies diluted in 1% BSA with PBS-T (0.1% Tween 20) for 1-2 h at 
room temperature or overnight at 4°C. To visualize primary antibodies, cells 
were incubated for 1 h at room temperature with secondary antibodies 
conjugated to Alexa fluorochromes 488, 555 or 633 (Invitrogen). DNA 
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was stained with DAPI (Sigma), and slides were mounted using Aqua-
Poly/Mount (Polysciences, Inc.). Antibodies used are summarized in 
Supplementary tables 1 and 2. Images were acquired using an LSM700 
microscope equipped with a 40x Plan-apochromat 1.3 NA oil immersion 
lens (Carl Zeiss Micro Imaging Inc.). Using FIJI image analysis software, 
we determined protein accumulation at lesion sites by dividing the 
overall fluorescence signal intensity at LUDs by the protein overall nuclear 
intensity. In Fig. 1f and Fig. 6g zero accumulation (nuclear background) 
was set at 0 and maximum accumulation (above nuclear background) in 
control conditions at 1.0.  
Fluorescence Recovery After Photobleaching (FRAP). FRAP 
experiments were performed as previously described61,63, using a Leica TCS 
SP5 microscope (with LAS AF software, Leica) equipped with a 40x/1.25 
NA HCX PL APO CS oil immersion lens (Leica Microsystems), at 37°C 
and 5% CO2. Briefly, a strip spanning the nucleus width (512x16 pixels) 
at 1400 Hz of a 488 nm laser, with a zoom of 12x was used to measure 
the fluorescence signal every 100 ms until a steady-state was reached 
(pre-bleach). Fluorescence signals were then photobleached using 100% 
power of the 488 nm laser and recovery of fluorescence in the strip was 
monitored every 22 ms until a steady-state was reached. Fluorescence 
signals were normalized to the average pre-bleach fluorescence after 
background signal subtraction. Three independent experiments were 
performed, with the acquisition of 10 cells for each condition in each 
experiment. The immobile fraction (Fimm), shown in Fig. 2c, was determined 
using the fluorescence intensity recorded immediately after bleaching (I0) 
and the average fluorescence signal after reaching steady-state from the 
unchallenged cells (Ifinal,unc) and UV-irradiated cells (Ifinal,UV)61:
     
 .
Real-time protein recruitment to UV-C laser induced damage. 
To induce local UV-C DNA damage in living cells, a 2 mW pulsed (7.8 kHz) 
diode pumped solid state laser emitting at 266 nm (Rapp Opto Electronic, 
Hamburg GmbH) coupled to a Leica TCS SP5 confocal microscope was 
used, as described previously62. Cells seeded on quartz coverslips were 
imaged and irradiated via a Ultrafluar quartz 100x/1.35 NA glycerol 
Fimm = 1 −  I�inal, UV − I0, UVI�inal, unc − I0, UV 
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immersion lens (Carl Zeiss Micro Imaging Inc.) at 37°C and 5% CO2. 
Resulting accumulation curves were corrected for background values and 
normalized to the relative fluorescence signal before local irradiation. 
Chromatin fractionation. U2OS cells were grown to confluency on 10 
cm dishes, UV-C irradiated with the indicated dose and lysed in lysis buffer 
(30 mM HEPES pH 7.6, 1 mM MgCl2, 130 mM NaCl, 0.5% Triton X-100, 0.5 
mM DTT and EDTA-free protease inhibitor cocktail (Roche)), at 4°C for 30 
min. Non-chromatin bound proteins were recovered by centrifugation (10 
min, 4°C, 16100 g). Chromatin-containing pellet was resuspended in lysis 
buffer supplemented with 250 U/µL of Benzonase (Merck Millipore) and 
incubated for 1 h at 4°C. Equal amounts of sample were used for SDS-
PAGE gels and immunoblotting analysis. 
Cycloheximide (CHX) protein stability assay. Protein synthesis was 
inhibited by adding 100 µM CHX (Enzo) to cells in culture. Concomitantly, 
for the experiment shown in Supplementary Fig. 3a, protein degradation 
was inhibited by adding 10 µM MG132 (Sigma) before the addition of 
CHX. Cells were lysed at the indicated time points after CHX addition, for 
30 min at 4°C in RIPA buffer (25 mM Tris-HCl pH 7.5, 150 mM NaCl, 6mM 
EDTA, 0.1% SDS, 1% Triton X-100, 1% NP-40, supplemented with EDTA-free 
protease inhibitor cocktail (Roche)). Whole cell extracts were recovered 
by centrifugation (20 min at 4°C and 1400 g) and quantified using the 
BCA Protein Assay Kit (Pierce, ThermoFisher Scientific). Equal amounts of 
protein from total cell lysates were used for immunoblot analysis.   
Immunoblotting. Protein samples (whole cell extracts or cell 
fractionations) were 2 x diluted in sample buffer (125 mM Tris-HCl pH 6.8, 
20% Glycerol, 10% 2-β-Mercaptoethanol, 4% SDS, 0.01% Bromophenol 
Blue) and boiled for 5 min at 98°C. Equal amounts of protein from whole 
cell lysates were separated in SDS-PAGE gels and transferred onto PVDF 
membranes (0.45 µm, Merck Millipore). After 1 h of blocking in 5% BSA 
in PBS-T (0.05% Tween 20), membranes were incubated with primary 
antibodies in PBS-T for 1-2 h at room temperature, or at 4°C overnight. 
Secondary antibodies were incubated for 1 h at room temperature. 
Membranes were washed 3 x 10 mins in PBS-T after antibody incubation. 
Probed membranes were visualized with the Odyssey CLx Infrared Imaging 
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System (LI-COR Biosciences). Antibodies are listed in Supplementary 
Table 1 and 2. Immunoblots were quantified using ImageStudio Lite (ver. 
5.2, LI-COR Biosciences). Full-size immunoblot scans are provided in 
Supplementary Fig. 6,7. 
Colony forming assays. For colony survival assays after DNA damage, 
cells were seeded in triplicate in 6-well plates (400 cells/well) and treated 
with increasing doses or concentrations of UV-C or cisplatin, respectively, 
1 day after seeding. After 5-7 days, colonies were fixed and stained. For 
the colony forming assay shown in Fig. 5d,e and Supplementary Fig. 4e, 
cells were seeded in triplicate in 6-well plates (750-1000 cells/well) 48 h 
after siRNA transfection. After 12 days, cells were fixed and stained. Fixing 
and staining solution: 0.1 % w/v Coomassie Blue (Bio-Rad) was dispersed 
in a 50% Methanol, 10% Acetic Acid solution. Colonies were counted with 
the integrated colony counter GelCount (Oxford Optronix).
Real-Time Reverse Transcriptase PCR (RT-qPCR). Total RNA was 
isolated from siRNA-transfected U2OS cells using the RNeasy mini kit 
(Qiagen). cDNA was synthesized using iScript cDNA Synthesis Kit (Bio-
Rad), accordingly to manufacturer’s instructions. TFIIH genes and GAPDH 
expression levels were analyzed using RT-qPCR with the PowerUP SYBR 
Green Master Mix (ThermoFischer Scientific) in a Bio-Rad CFX96 device. 
Primers used are listed in Supplementary Table 3. The relative gene 
expression of TFIIH genes was calculated according to the comparative 
quantification cycle (Cq) method and normalized to GAPDH expression. 
The expression level of each TFIIH gene in BRM knockdown cells was 
normalized to expression in control siRNA treated cells. Expression levels 
were measured in triplicate in two independent experiments. 
Re-analysis of public Chip-seq data. To dissect BRG1/BRM enrichment 
in GTF2H1, we re-analyzed published BRG1/BRM ChIP-seq datasets from 
liver cancer HepG2 cells upon transfection with non-targeting shRNA 
(Fig. 3c; GEO accession GSE10255932) and BRG1/BRM ChIP-seq datasets 
from RWPE1-SCHLAP1 cells (Supplementary Fig. 3c; GEO accession 
GSE11439233). ChIP-seq raw data was obtained from the Sequence Read 
Archive repository (SRA, NCBI; SRP115303 and SRP145601) and uploaded 
to the Galaxy platform64. Reads were aligned to the human genome (hg19 
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build) with BWA (Galaxy Version 0.7.17.4), poor quality alignments and 
duplicates were subsequently filtered with SAMtools (Galaxy Version 1.1.2) 
–q 20. To visualize ChIP-seq signal density, replicate datasets were merged 
with SAMtools and further processed using bamcoverage tool (Galaxy 
Version 2.5.0.0), DeepTools suit65 with binsize 30, reads extended to 150 bp 
and normalized to reads per kilobase per million (RPKM); resulting bigwig 
files were visualized using IGV genome browser66. Peaks were determined 
with MACS2 peak caller (Galaxy Version 2.1.1.20160309.067) using the 
predictd function to estimate fragment size for all datasets and the 
following analysis parameters –qval=0.01 –nomodel –extsize=d –broad 
-broadcutoff 0.05 –keepdup-all. Resulting peaks were filtered against the 
ENCODE blacklist regions and finally visualized in IGV browser. Promoter 
region annotation for GTF2H1 gene was obtained from the Ensembl 
database (GRCh37 assembly, Chr11: 18,340,602-18,346,999).
Immunoprecipitation. The procedure for in vivo crosslink and 
immunoprecipitation was described previously12 and applied with minor 
alterations. Briefly, after UV-C irradiation (20 J/m2), cells were cultured for 
30 min before crosslinking in 1% paraformaldehyde in PBS for 5 min at 
room temperature. Crosslinking reaction was stopped with 0.125 M of 
glycine and cells were collected in ice cold PBS supplemented with 1 mM 
PMSF and 10% glycerol. All subsequent steps were performed at 4°C. 
Following centrifugation, cell pellet was resuspended in lysis buffer (50 
mM HEPES pH 7.8, 0.15 M NaCl, 0.5% NP-40, 0.25% Triton X-100, and 
10% glycerol). After 30 min incubation, the suspension was spun down, 
and supernatant (soluble fraction) was removed. The pellet was washed 
with Wash buffer (0.01 M Tris-HCl pH 8.0, 0.2 M NaCl), spun down and 
resuspended in 1 × RIPA buffer (0.01 M Tris-HCl pH 7.5, 0.15 M NaCl, 
1% Triton X-100, 1% NP-40, 0.1% SDS). Chromatin was sheared using a 
Bioruptor Sonicator (Diagenode) using cycles of 30 s ON, 30 s OFF during 
10 min, after which samples were centrifuged. The supernatant containing 
crosslinked chromatin was used for immunoprecipitation. All buffers were 
supplemented with 0.1 mM EDTA, 0.5 mM EGTA, 1 mM PMSF and a mixture 
of proteinase and phosphatase inhibitors. For immunoprecipitation, 
extracts were incubated with GFP-trap beads (Chromotek), overnight at 
4°C. Subsequently, beads were washed 5 times in RIPA buffer and elution 
of the precipitated proteins was performed by extended boiling in 2x 
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Laemmli sample buffer for immunoblotting analysis.  
Cell cycle profiling. For cell cycle analysis, cells were fixed in 70% ethanol, 
followed by DNA staining with 50 µg/ml propidium iodide (Invitrogen) in 
the presence of RNase A (0.1 mg/mL). Cell sorting was performed on a BD 
LSRFortessaTM flow cytometer (BD Bioscience) using FACSDiva software. 
Obtained data was quantified with Flowing software 2.5.1 (by Perttu Terho 
in collaboration with Turku Bioimaging).
Statistical Analysis. Mean values and S.E.M. error bars are shown for 
each experiment. Unpaired, two-tailed t tests were used to determine 
statistical significance between groups. In all experiments, between-group 
variances were similar and data were symmetrically distributed. For analysis 
of graphs in Fig. 2a and Supplementary Fig. 1g, a ROC curve analysis was 
performed with significance levels set to 0.05. All analysis were performed 
using Graph Pad Prism version 7.03 for Windows (GraphPad Software, La 
Jolla California USA). P values expressed as * P< 0.05; ** P< 0.01, ***P< 
0.001 were considered to be significant. n.s., non-significant.  
Data availability
The raw ChIP-seq data sets analyzed during the current study were 
obtained via the Sequence Read Archive repository (SRA, NCBI), [https://
www.ncbi.nlm.nih.gov/sra], with the data set identifiers SRP115303 and 
SRP145601. Other relevant data generated during the current  study are 
available from the corresponding author on reasonable request. Individual 
data points are provided in Supplementary data file 1. 
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Supplementary Fig. 1. BRM is required for recruitment of XPB but not of GG- and TC-NER damage 
sensor proteins XPC and CSB. (a,b) Immunoblot analysis of total cell lysates demonstrating siRNA-
mediated downregulation of BRM, BRG1 and XPA in (a) C5RO (related to Fig. 1a,b) and (b) U2OS cells 
(related to Fig. 1c,d). The same total amount of protein from each cell lysate was loaded in each lane. (c) 
Immunofluorescence images demonstrating BRM siRNA-mediated depletion in U2OS cells (related to Fig. 
1e,f). Scale bar: 50 µm. (d) XPC-GFP and (e) GFP-CSB accumulation at LUD, induced with a 266 nm UV-C 
laser, measured in real time by confocal imaging. Pre-damage relative fluorescence intensity was set to 
100% (t=0). (d) XP4PA with stable XPC-GFP expression were treated with control (CTRL) or BRM siRNAs. 
Representative results of three independent experiments with similar results (mean & S.E.M., at least 10 
cells per condition in each experiment). (e) CS1AN cells with stable GFP-CSB expression were treated with 
control (CTRL) or BRM siRNAs (mean & S.E.M. of at least 10 cells per condition). (f) Immunoblot analysis 
of total cell lysates demonstrating siRNA-mediated downregulation of BRM in XPCS2BA patient cell lines 
complemented with XPB-GFP, referring to Fig. 2a,b. The same total amount of protein from each cell lysate 
was loaded in each lane. (g) XPB-GFP accumulation at LUD, induced with a 266 nm UV-C laser, measured in 
real time by confocal imaging. Pre-damage relative fluorescence intensity was set to 100% (t=0). XPCS2BA 
cells with stable expression of XPB-GFP were treated with control (CTRL) and BRM siRNAs. Mean & S.E.M. of 
at least 10 cells per condition, P< 0.0001, relative to siCTRL. (h) FRAP analysis of XPB-GFP in mock treated or 
UV-irradiated (10 J/m2) XPCS2BA cells transfected with control (CTRL) or BRM siRNAs. XPB-GFP was bleached 
in a strip across the nucleus and fluorescence recovery was measured over 50 s and normalized to pre-
bleach. The immobile XPB-GFP fraction depicted in Fig. 2c was calculated after subtracting the bleach-depth 
intensities, by dividing the average recovered fluorescence intensity of UV-irradiated cells by the average 
recovered fluorescence intensity of mock treated cells, over the last 10 s of the measurements as explained 
in the methods. FRAP graph is the average of 3 independent experiments, with at least 10 cells measured 
per condition each time. 
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Supplementary Fig. 2. BRM and BRG1 are not localized to sites of UV damage. (a) Relative quantification 
of the immunostaining of soluble (nucleoplasm) XPB and XPD (shown in Fig. 2d) from U2OS cells treated with 
control (CTRL) or BRM siRNAs before and after (5 and 30 min) UV-C irradiation (20 J/m2). Mean & S.E.M. of 
two independent experiments. (b) Immunofluorescence showing absence of recruitment of BRM and BRG1 
to LUD in U2OS cells. Cells were fixed 30 min and 1 h after inducing LUD with UV-C irradiation (60 J/m2) 
through a microporous membrane (8 µm). UV lesions were marked with staining against CPD (red channel). 
Scale bar: 5 µm. (c) XPC-GFP (in XP4PA), BRM-GFP and BRG1-GFP (in U2OS) accumulation at LUD, induced 
with a 266 nm UV-C laser, measured in real time by confocal imaging. Pre-damage relative fluorescence 
intensity was set to 100% (t=0). Mean & S.E.M. of at least 15 cells per condition. (d) Immunoblot analysis of 
input and GFP immunoprecipitation (IP) from XPB-GFP expressing XPCS2BA cells, 30 min after mock (UV-) 
or global UV-C (20 J/m2; UV+) treatment and from non-treated XPCS2BA control cells, without XPB-GFP (C). 
Samples were analyzed with antibodies against XPB, GTF2H1 and BRM. 
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Supplementary Fig. 3 | Lower GTF2H1 expression after BRM or BRG1 knockdown affects TFIIH 
stability and function. (a) Immunofluorescence of GTF2H1 and BRM protein levels in U2OS cells treated 
with control (CTRL) or BRM siRNA RNA. For BRM, an independent siRNA (BRM#2) was used to exclude off-
target effects. Scale bar: 50 µm. (b) Quantification of GTF2H1 and BRM fluorescence intensity, shown in (a). 
Total levels of GTF2H1 and BRM were normalized to control (CTRL) siRNA, set to 1.0 (mean & S.E.M. of three 
independent experiments, with > 110 cells per sample per experiment). ***P < 0.001, relative to siCTRL. (c) 
BRG1 and BRM co-occupancy of GTF2H1 promotor in RWPE1 cells. Re-analysis of published BRG1 and BRM 
ChIP-seq data from RWPE1 cells (overexpressing lncRNA SCHLAP1) in which ChIP-seq signal density (top) 
and respective peaks (bottom) illustrate BRG1 (purple) and BRM (green) enrichment at the promoter of 
GTF2H1 (GEO accession GSE114392). Promoter region is highlighted in light orange, signal density in reads 
per million. (d) XPB stability was analyzed in U2OS cells treated with control (CTRL) siRNA and with 100 µM 
cycloheximide (CHX) to inhibit protein synthesis. Cells were pretreated with 50 µM of proteasome inhibitor 
MG-132, 45 min prior to CHX addition. DDB2 immunostaining was used as loading control. Representative 
immunoblots of two independent experiments with similar results. (e) Quantification of TFIIEβ protein levels 
normalized to DDB2 in time after addition of cyclohexamide (CHX) in U2OS cells treated with control (CTRL) 
or BRM siRNAs (as shown in Fig. 3d). The total amount of TFIIEβ in whole cell lysates was set to 1.0 at t=0 in 
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each condition. Mean & S.E.M. of two independent experiments. (f) Immunoblots of BRM, BRG1 and GTF2H1 
protein levels from whole cell lysates of U2OS cells treated with non-targeting (CTRL), BRM or BRG1 siRNAs. 
Tubulin was used as a loading control to normalize quantified GTF2H1 protein levels, indicated below the 
blot (normalized to siCTRL, set to 100%). (g) Immunofluorescence of GTF2H1 and BRG1 protein levels after 
BRG1 siRNA-mediated depletion with two additional independent siRNAs (BRG1#2, BRG1#3) in U2OS cells, 
to exclude off-target effects. Scale bar: 50 µm. (h) Quantification of GTF2H1 and BRG1 fluorescence intensity, 
shown in (g). Total levels of GTF2H1 and BRG1 were normalized to control (CTRL). Mean & S.E.M. of three 
independent experiments with > 110 cells per sample per experiment. **P< 0.01, ***P< 0.001, relative to 
siCTRL. (i) Immunofluorescence of XPD recruitment (red channel) to LUD marked by XPC (cyan channel) 
in U2OS cells treated with control (CTRL) or BRG1 siRNAs. U2OS cells were fixed 30 min after local UV-C 
irradiation (60 J/m2) through a microporous membrane (8 µm) Scale bar: 5 µm. (j) Knockdown of BRM 
or BRG1 does not affect cell cycle distribution. U2OS cells were transfected with the indicated siRNAs or 
mock treated (NT). The average percentage of cells in G1 (dark purple), S (lighter purple) and G2/M (light 
pink) phase is presented. Mean & S.E.M. of at least two independent experiments. (k) Quantification of XPD 
recruitment to UV-lesions within 30 mins after UV-C irradiation (60 J/m2) in U2OS cells treated with control 
(CTRL), BRM, BRG1 and GTF2H1 siRNAs. Relative accumulation of XPD at LUD (over nuclear background) in 
each condition was normalized to cells treated only with siCTRL, in which nuclear background was set as 0 
and maximal signal at LUD set to 1.0 (>47 cells per sample, mean & S.E.M.). ***P< 0.001, relative to cells 
treated only with siCTRL. 
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Supplementary Fig. 4. GTF2H1 expression in SWI/SNF-deficient cancer cell lines. (a) Immunofluorescence 
analysis of GTF2H1, BRM and BRG1 levels in SWI/SNF-deficient cancer cell lines SW13 (adrenal cortex), A2780 
(ovarian), Panc-1 (pancreatic), C33A (cervix), Hs 597T (breast) and Hs 700T (pancreatic). As reference, U2OS 
(osteosarcoma) and MRC5 (human fibroblasts) were used. Scale bar: 50 µm. (b) Quantification of GTF2H1, 
BRM and BRG1 fluorescence intensity, shown in (a). Total protein levels were normalized to MRC5, set to 
1.0. Mean & S.E.M. of four (GTF2H1) and two (BRM, BRG1) independent experiments with > 100 cells per 
sample per experiment. *P< 0.05, **P< 0.01, ***P< 0.001, relative to MRC5. n.s., non-significant. (c) Whole 
cell lysate of H1299 cells with and without stable expression of GFP-GTF2H1, treated with control (CTRL), 
BRM or BRG1 (BRG1#2) siRNAs, were analyzed by immunoblotting against BRG1, BRM and GTF2H1. Ku70 
was used as loading control. (d) Relative quantification of ectopic GFP-GTF2H1 and endogenous GTF2H1 
levels in H1299 (depicted in c) and A549 (depicted in Fig. 5c) cells, with and without stable expression of 
GFP-GTF2H1, treated with control (CTRL), BRM or BRG1 (BRG1#2) siRNAs. GFP-GTF2H1 and GTF2H1 levels 
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 were normalized to Ku70 and to siCTRL, set to 1.0 (mean & S.E.M. from two independent experiments). 
(e) H1299 cells, with or without stable expression of GFP-GTF2H1 were seeded 48 h after transfection with 
control (CTRL), BRM or BRG1 (BRG1#2) siRNAs, in triplicate, at a density of 750 cells per well and grown for 
12 before fixation and staining.
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Supplementary Fig. 5. Cells with permanent loss of BRM or BRG1 can restore GTF2H1 expression 
levels. (a) Immunofluorescence analysis of GTF2H1 levels in MRC5 WT cells and heterogeneous pool of 
sgBRM or sgBRG1 transfected cells. Arrows depict cells that have retained low GTF2H1 levels. To verify 
the knockouts, specific antibodies against BRM or BRG1 were used (green channel). Scale bar: 25 µm. (b) 
Immunofluorescence analysis of BRM and GTF2H1 levels in MRC5 WT and single BRM knockout (sgBRM) 
clones. (c) Sequence of the sgBRM target region in MRC5 BRM knockout clones c1, c3, c6 and c7. Blue 
indicates the sgBRM target sequence. Red indicates the PAM sequence. All deletions (in alleles of c1, c3, c6 
and c7) and the insertion (in one of the alleles of c7) are predicted to severely truncate BRM. (d) Immunoblot 
analysis of GTF2H1 levels in U2OS cells without and with stable ectopic expression of BRG1-GFP, treated with 
control (CTRL) or BRM siRNAs. Immunoblots were stained against GTF2H1, BRM, BRG1 and Ku70 as loading 
control.  
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Supplementary Fig. 6. Full-size immunoblot scans shown in Fig. 2d (a), Fig. 3d (b) and Fig. 3d (c). 
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Supplementary Fig. 7. Full-size immunoblot scans shown in Fig. 5a (a), Fig. 5c (b), Fig. 6a (c) and Fig. 6e (d). 
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Supplementary Table 1. Primary Antibody list and working dilutions.
Dilutions
Source, Reference Antibody Immunoblotting Immunofluorescence
Abcam, ab181136 DDB2 1/1000 1/1000
Bethyl, A301-121A XPC 1/2000 1/2000
Santa Cruz, sc-293 XPB 1/1000 1/1000
Abcam, ab54676 XPD 1/1000 1/150
Abcam, ab55199 GTF2H1 1/500 1/500
Sigma, WH0002965M1 GTF2H1 1/500 1/500
Novus Biologicals, NBP2-38556 GTF2H1 1/500 1/200
Santa Cruz, sc-853 XPA 1/250 1/50
Santa Cruz, sc-136153 XPF N.A. 1/100
MBL international, TDM-2 CPD N.A. 1/1000
Abcam, ab15597 BRM 1/800 1/250
Santa Cruz, sc-6450 BRM N.A. 1/200
Sigma Aldrich, B8184 BRG1 1/3000 1/1000
Abcam, ab110641 BRG1 1/10000 1/500
2D4 clone CCNH 1/1000 N.A.
Abcam, ab17677 Histone H1.2 1/1000 N.A.
Abcam, ab187143 TFIIEβ 1/1000 N.A.
Santa Cruz, sc-1487 Ku70 1/1000 N.A.
Santa Cruz, sc-17789 Ku70 1/1000 N.A.
Sigma Aldrich, B512 Tubulin 1/10000 N.A.
Supplementary Table 2. Secondary Antibody list and working dilutions.
Dilutions
Source, Reference Antibody Immunoblotting Immunofluorescence
Sigma, sab4600215 Anti-rabbit, CF IRDye 770 1/10000 N.A.
Sigma, sab4600200 Anti-rabbit, CF IRDye 680 1/10000 N.A.
Sigma, sab4600214 Anti-mouse, CF IRDye 770 1/10000 N.A.
Sigma, sab4600199 Anti-mouse, CF IRDye 680 1/10000 N.A.
Sigma, sab4600375 Anti-goat, CF IRDye 770 1/10000 N.A.
Invitrogen, A11034 Anti-rabbit, Alexa Fluor 488 N.A. 1/1000
Invitrogen, A21429 Anti-rabbit, Alexa Fluor 555 N.A. 1/1000
Invitrogen, A21207 Anti-rabbit, Alexa Fluor 594 N.A. 1/1000
Invitrogen, A21072 Anti-rabbit, Alexa Fluor 633 N.A. 1/1000
Invitrogen, A11001 Anti-mouse, Alexa Fluor 488 N.A. 1/1000
Invitrogen, A21424 Anti-mouse, Alexa Fluor 555 N.A. 1/1000
Invitrogen, A21467 Anti-goat, Alexa Fluor 488 N.A. 1/1000
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Supplementary Table 3. List of primers used for RT-qPCR.
Gene Sense primer Antisense Primer Amplicon size (bp)
CCNH 5’- TCACCCCAGGATAATAATGCTCA-3’ 5’-CAGTATCTGTTCAAGTGCCTTCT-3’ 136
CDK7 5’-GGAGCCCCAATAGAGCTTATACA-3’ 5’-TCCACACCTACACCATACATCC-3’ 97
GTF2H1 5’-GACCTTGTTGTGAGTCAAGTGA-3’ 5’-CCTGCTTATGATTGGATGTGGAA-3’ 100
GTF2H2 5’-CGTATGGGATTTCCTCAGCAC-3’ 5’-AGCCTCCTAATGTAAGCCCTG-3’ 115
GTF2H3 5’-GAATGGCAGACTTGGAGACTTC-3’ 5’-GCAAAGTTTCTGTATGTTGACCC-3’ 176
GTF2H4 5’-ACCCCATTTTCCGCCAGAAC-3’ 5’- CGGCGTACTTGTCAAGGGAG-3’ 126
GTF2H5 5’-AAGACATTGATGACACTCACGTC-3’ 5’-GGGAAAAAGCATTTTGGTCCATT-3’ 96
MNAT1 5’-GGTTGCCCTCGGTGTAAGAC-3’ 5’-AGTTGCTCTTTCTGAGTGGAGT-3’ 160
ERCC3 5’-CTAACTGCCTACTCCTTGTATGC-3’ 5’-TCCATAGCTGACAGTACACAACT-3’ 141
ERCC2 5’-AGAAGGTGATTGAAGAGCTTCG-3’ 5’-ACCTCAGGGTGAATACACAAGT-3’ 121
GAPDH 5’-AAGGTGAAGGTCGGAGTCAA-3’ 5’-ACCATGTAGTTGAGGTCAATG-3’ 125
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Abstract
SWI/SNF complexes are among the most studied ATP-dependent 
chromatin remodeling complexes, mostly due to their critical role in 
coordinating chromatin architecture and gene expression. Mutations in 
genes encoding SWI/SNF subunits are frequently observed in a large 
variety of human cancers, suggesting that one or more of the multiple SWI/
SNF functions protect against tumorigenesis. Chromatin remodeling is an 
integral component of the DNA damage response (DDR), which safeguards 
against DNA damage-induced genome instability and tumorigenesis by 
removing DNA damage through interconnected DNA repair and signaling 
pathways. SWI/SNF has been implicated in facilitating repair of double-
strand breaks, by non-homologous end-joining as well as homologous 
recombination, and repair of helix-distorting DNA damage by nucleotide 
excision repair. Here, we review current knowledge on SWI/SNF activity in 
the DDR and discuss the potential of exploiting DDR-related vulnerabilities 
due to SWI/SNF dysfunction for precision cancer therapy. 
Keywords: SWI/SNF; DNA damage response; homologous recombination; non-
homologous end-joining; nucleotide excision repair; cancer therapy
List of abbreviations: DDR (DNA damage response), double strand break (DSB), 
homologous recombination (HR), non-homologous end-joining (NHEJ), nucleotide 
excision repair (NER), ultra-violet (UV), ionizing radiation (IR), cyclobutane-pyrimidine 
dimers (CPDs), 6-4 pyrimidine-pyrimidone photoproducts (6-4PPs), transcription-coupled 
NER (TC-NER), global genome NER (GG-NER). 
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1. Introduction
On a daily basis, each of our cells accumulates up to 104-105 DNA lesions 
that, if not adequately dealt with, can interfere with vital cellular processes 
such as transcription and replication, promoting genomic instability and 
eventually leading to tumorigenesis and premature aging1,2. DNA lesions 
are a fact of life as they originate, to a large extent, from the spontaneous 
chemical instability of DNA in the cell’s aqueous milieu, such as hydrolysis 
of bases, or from chemical attack by intracellular metabolites, such as 
reactive oxygen species derived from oxidative respiration. Genomic stress 
is further aggravated by exposure to a range of environmental chemicals 
and radiation. Some of the best studied environmental genotoxic 
agents are ultra-violet (UV) light, ionizing radiation (IR) and inter-strand 
crosslinking agents, due to their relevance for cancer development. 
Paradoxically, the latter two are also commonly used to treat cancer in 
radiotherapy and chemotherapy, respectively. Because DNA cannot 
be replaced, removal of damage is vital to protect cells against genetic 
erosion and transcription and replication stress. Evolution equipped 
cells with a sophisticated portfolio of specialized DNA repair and DNA 
damage signaling pathways, collectively called the DNA damage response 
(DDR), to cope with the different types of DNA lesions1,3. A few of the 
different DNA repair pathways, relevant for this review, will be discussed 
in more detail below. The type of DNA lesion, its genomic location and 
chromatin environment, and the cell cycle phase determine which repair 
pathway is activated. Moreover, like all DNA-associated processes, DNA 
repair pathways have to overcome the physical barrier imposed by the 
condensed packaging of DNA into chromatin to efficiently access, detect, 
and repair lesions at any genomic location4,5. In recent years, the number 
of chromatin modifying and remodeling enzymes found important for 
efficient DNA repair has increased tremendously, evidencing that (re-)
organization of the highly dynamic chromatin structure is an intricate and 
essential component of the DDR in vivo6. 
The nucleosome is the basic unit of chromatin, comprising approximately 
146/147 bp of DNA wrapped around a histone octamer containing two 
copies of histones H2A, H2B, H3 and H47. Each nucleosome is stabilized by 
electrostatic interactions between the phosphate backbone of DNA and 
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positively charged residues on histones, while short linker DNA segments 
link nucleosomes together. Folding and compaction of DNA into high-
order structures is achieved by short and long-range interactions between 
nucleosomes, linker histone H1 and additional non-histone proteins. 
Dynamic rearrangement of the chromatin structure, via the concerted 
action of histone modifiers, histone chaperones, and ATP-dependent 
chromatin remodeling complexes, regulates the access and activity of 
DNA-transacting enzymes, including that of DDR proteins8. In eukaryotes, 
many structurally related ATP-dependent chromatin remodeling proteins 
and complexes have been identified, including the four major families, SWI/
SNF, INO80, CHD, and ISWI, many of which have been implicated in DDR9–
11. Importantly, defects in both ATP-dependent chromatin remodelers12 
and DDR2 are associated with tumorigenesis, but the interplay between 
these two with respect to cancer development is unfortunately only 
partially understood and currently an active field of research. In particular, 
the family of SWI/SNF chromatin remodeling complexes is frequently 
mutated in a wide variety of human cancers13. Therefore, we focus in this 
review on their emerging function in the DDR, specifically on their role 
in DNA double-strand break (DSB) repair and nucleotide excision repair 
(NER) and speculate on how this gained insight could be exploited for 
the development of new cancer prognostic markers, and therapeutic 
interventions. 
2. SWI/SNF ATP-dependent chromatin remodelers
2.1 SWI/SNF complex composition and chromatin remodeling 
function 
SWI/SNF (switching defective/sucrose non-fermenting) complexes were 
named after the two phenotypes in yeast that led to their discovery, 
through genetic screening for genes that regulate mating type switching 
and activate sucrose fermentation pathways14–16. Evolutionary homologs of 
these multi-subunit protein complexes were later identified in Drosophila 
and mammals, and their role as major global regulators of transcription 
through ATP-dependent chromatin remodeling was firmly established17–19. 
SWI/SNF are heterogeneous complexes with the necessary skillset 
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for diverse and specialized functions required in different cellular and 
developmental contexts20,21. Mammalian SWI/SNF complexes always 
contain one of two mutually exclusive, though structurally highly related 
ATPases: BRM/SMARCA2 or BRG1/SMARCA4 (Fig. 1a, Table 1). These 
proteins couple ATP hydrolysis with directional translocation over DNA, 
thereby either repositioning nucleosomes, exchanging nucleosomes 
histone dimers or evicting entire histone octamers8,22 (Fig. 1b).  In addition 
to the defining ATPase domain, BRM and BRG1 harbor domains for 
binding to actin and other proteins, such as the HSA and QLQ domains23, 
and a bromodomain (BROMO) for binding to acetylated histones24 (Table 
1, Fig. 1c). Although BRG1 or BRM alone are sufficient for remodeling of 
nucleosomes in vitro25, in the context of the cell the additional SWI/SNF 
core and accessory subunits play essential roles in targeting and regulating 
their remodeling activity26,27. Depending on their subunit composition, 
SWI/SNF complexes are divided into two main categories, BAF and PBAF 
ARID1
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Figure 1. SWI/SNF ATP-dependent chromatin remodeling complexes. (a)  BAF and PBAF complexes are 
the two major subtypes of SWI/SNF complexes and are determined by their subunit composition 12,13,28,29,106,107. 
(b) ATP-dependent chromatin remodeling activity of SWI/SNF complexes couples ATP-hydrolysis with 
directional movement of SWI/SNF that disrupts histone-DNA interactions at local nucleosomes 8,22. (c) BRM 
and BRG1 share the same functional domains that regulate sequence-specific DNA (BR, Bromo, and HAS, 
Helicase/SANT-associated) and protein (QLQ, Gln-Leu-Gln motif) interactions. 
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(Fig. 1a). In humans, SNF5/SMARCB1, BAF155/SMARCC1, and BAF170/
SMARCC2 are core SWI/SNF subunits found in every SWI/SNF complex 
(Fig. 1a, dark blue ovals)25. BAF250A/ARID1A or BAF250B/ARID1B, BRD9 
and SS18 are found exclusively in BAF complexes (Fig. 1a, grey ovals), while 
BAF200/ARID2, BAF180/PBRM1, PH10 and BRD7 are found solely in PBAF 
(polybromo BRG1-associated factor) complexes (Fig. 1a, white ovals)13,28. 
Also, some accessory (family of) proteins are shared by BAF and PBAF, e.g., 
BAF57, β-actin, ACTL6 (A/B), BLC7(A/B/C) and DPF(1/2/3) (Fig. 1a, light blue 
ovals). Most subunits harbor one or more unique domain (Table 1), with 
which they tightly coordinate SWI/SNF function. For instance, subunits 
such as BAF180 and BRD7 harbor BROMO domains that allow SWI/SNF 
to interact with acetylated histones, while ARID and Zinc finger domains 
in ARID1A/B and ARID2 provide SWI/SNF with the ability to interact with 
specific DNA sequences28–30. 
In BAF complexes either BRM or BRG1 can be the catalytic subunit, whereas 
in PBAF that function is exclusively performed by BRG1. Many accessory 
subunits are encoded by sets of paralogs that are mutually exclusive 
and thus not present within the same complex: ACTL6A/B, DPF1/2/3, 
SMARCD1/2/3, and ARID1A/B13,28. Thus, the combination of different SWI/
SNF subunits, encoded by at least 29 genes from 15 gene families29 can 
potentially give rise to an undetermined number of distinct complexes of 
different biological functions, with specific combinations being unique to 
certain cell types. Cellular transitions, for instance during differentiation, 
can lead to dynamic reconfiguration of SWI/SNF complex composition. 
One example of this is the replacement of ACTL6A by ACTL6B, which is 
essential for proper neuron function during neuronal differentiation30. 
However, the impact of changes in subunit composition to the various 
functions of SWI/SNF complexes, in particular also to their function in the 
DDR, is far from understood. 
2.2 Tumor suppressor functions of SWI/SNF 
Mutations in genes encoding for SWI/SNF subunits are found in 
approximately 20% of all human cancers of various types13,31 (Table 1). This 
suggests that SWI/SNF may act as a tumor suppressor, thus protecting 
against cancer development, likely by regulating processes that safeguard 
cellular homeostasis. It is therefore relevant to understand how SWI/SNF 
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Table 1. SWI/SNF subunits, domains and frequency of alteration in cancer.
Subunit HUGO name Synonyms Domains % Alteration in cancer
BRG1 SMARCA4 -
Bromo, 
ATPase, HAS, 
QLQ
Ovarian cancer (>10%), 
medulloblastoma (5-10%), melanoma 
(5-10%), small cell cancer of the ovary 
(100%)
BRM SMARCA2 - Bromo, ATPase
Rhabdoid tumor (60%); lung (4.8-10%), 
breast (15%), gastric (15%) and bladder 
(15%) cancers
SNF5 SMARCB1 INI1, BAF47 COIL
Rhabdoid tumor (>98%), epithelioid 
sarcomas (>55%), familial 
schwannomatosis (30-45%)
BAF155 SMARCC1 - CHROMO, SANT, COIL Prostate cancer (30-31%)
BAF170 SMARCC2 - CHROMO, SANT, COIL Rarely mutated
ARDI1A ARDI1A BAF250A ARID
Clear cell ovarian (50%), endometrioid 
ovarian (21-48%), breast (2.5%), liver 
(15%), bladder (17%), gastric (14-18%), 
lung (9.8%) cancer
ARDI1B ARDI1B BAF250B ARID
Childhood neuroblastoma (7%), clear 
cell ovarian (>10%), gastric, colorectal 
and liver cancer (5-10%)
ARID2 ARID2 BAF200 ARID, Zinc 
finger
Melanoma (5-15%), lung and 
colorectal (5-10%) and liver (5-14%) 
cancer
BAF180 PBRM1 - Bromo, HMG Renal cancer (41%), epithelioid sarcoma (83%)
BRD7 BRD7 - Bromo Breast cancer
BRD9 BRD9 - Bromo Rarely mutated
PH10 PH10 BAF45A PHD finger Rarely mutated
DPF1/2/3 DPF1/2/3 BAF45B/C/D PHD finger Rarely mutated
BAF57 SMARCE1 - HMG, COIL Familial spinal meningiomas (45%)
SMARCD1/2/3 SMARCD1/2/3 BAF60A/B/C SWIB Rarely mutated
BCL7A/B/C BCL7A/B/C - - Non-Hodgkin’s lymphoma (19.7%)
ACTL6A/B ACTL6A/B BAF53A/B Actin Rarely mutated
SS18 SS18 SSXT - Synovial sarcoma (100%)
SWI/SNF subunits contain different protein domains to coordinate protein-protein or protein-DNA 
interactions22. Bromodomain (Bromo), important for the binding of acetylated histones. Coiled coil region 
(COIL) is a homodimerization domain. Chromatin organization modifier (CHROMO) domain is important for 
chromatin targeting. The Helicas/SANT-associated (HAS), SANT, ARID and HMG domains regulate sequence-
specific DNA interactions, while the Gln-Leu-Gln (QLQ) motif, Zinc finger and PHD domains are involved 
in protein-protein interactions. SWI/SNF subunits alterations in cancer summarized here are extensively 
described in recent reviews13,28,39,105. 
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activity contributes to the tumorigenesis process. The first uncovered and 
most studied function of SWI/SNF is its intricate regulation of transcription. 
Mammalian SWI/SNF complexes regulate transcription by binding in 
close vicinity to promoters but also near other regulatory regions, such 
as enhancers26,32. By promoting or repressing the expression of specific 
genes, SWI/SNF complexes control vital cellular processes32, including 
pluripotency of embryonic stem cells, cell cycle regulation and neuronal 
and hematopoietic cell differentiation33. Not only the ATPases BRG1 or 
BRM are needed for transcription regulation, but other SWI/SNF subunits 
play an important role in transcription by directly stimulating or inhibiting 
other transcriptional regulators. For instance, ARID1A/B and SNF5 can 
interact with the proto-oncogenic MYC protein to regulate the expression 
of its target genes, but can also modulate the expression of MYC itself34,35. 
Because MYC is an oncogene frequently overexpressed in cancer, tight 
control of its activity is desired, which could be potentially compromised 
in SWI/SNF-deficient cancers. Similarly, direct binding of BRM or BRG1 to 
the tumor suppressor RB136 facilitates the repression of RB1 targets, such 
as E2F transcription factors, and promotes G1 arrest37. Thus, inactivation 
of SWI/SNF leading to loss of RB1 activity may result in uncontrolled cell 
cycle progression and favor the appearance of malignant phenotypes.
SWI/SNF has additional functions beyond the regulation of gene expression, 
which are vital to safeguard genome function and stability and to prevent 
cancer, as described extensively in recent reviews28,31,38–40. Examples include 
the regulation of alternative splicing, by favoring recruitment of the splicing 
machinery41, and the regulation of decatenation activity of topoisomerase 
IIα (TOPIIα)42. Furthermore, the PBAF complex assists in sister chromatid 
cohesion by localizing at kinetochores of mitotic chromosomes43 and by 
regulating centromeric cohesion in a transcription-independent manner44. 
Because centromeric cohesion is crucial for chromosome orientation and 
proper segregation, loss of not only BAF180 but also BRG1 results in cells 
with abnormal anaphase events, aneuploidy, and micronuclei44,45. All of 
these aberrant events are typical features of many cancers, suggesting 
that SWI/SNF-mediated centromere cohesion is required for tumor 
suppression.
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3. SWI/SNF and the DNA damage response 
SWI/SNF has been implicated in multiple DNA repair pathways, which 
may have significant repercussions for tumorigenesis of SWI/SNF-
deficient cancers since DDR deficiencies often lead to genomic instability. 
Furthermore, knowing which SWI/SNF factors are actively involved in 
protecting cells against DNA damage would allow us to have a more 
comprehensive understanding of which DDR-related cancer vulnerabilities 
could be targeted as a consequence of SWI/SNF deregulation. Moreover, 
it would help to predict chemotherapy sensitivity of SWI/SNF-deficient 
cancer cells in precision medicine procedures.
3.1 Double-strand break repair 
SWI/SNF deficiency has been found to render yeast, C. elegans and human 
cells hypersensitive to DNA-damaging agents, including chemotherapeutic 
drugs such as doxorubicin and cisplatin, UV light and IR46–51. IR and 
chemotherapeutic drugs, the latter by interfering with replication, cause 
DSBs. When not properly repaired, these DSBs can result in mutations and 
chromosomal aberrations (e.g., translocations) that underlie oncogenic 
transformation. DSBs are predominantly repaired by non-homologous 
end-joining (NHEJ) and homologous recombination (HR)52. NHEJ takes 
place during any stage of the cell cycle and is initiated when broken 
DNA ends are bound by the KU70/KU80 heterodimer, which recruits 
and orchestrates the activity of subsequent repair factors that process 
and join DNA ends by ligation. Alternatively, in late S or G2 cell cycle 
phase, DSB ends are bound by the MRE11-RAD50-NBS1 (MRN) complex, 
which, together with CtIP and EXO1, resects one strand to create 3’ single 
stranded DNA overhangs to direct repair towards HR. In contrast to NHEJ, 
HR is more accurate and principally error-free, as it makes use of the sister 
chromatid as a template for homology-directed repair. MRN also recruits 
the phosphatidylinositol 3-kinase ATM, which phosphorylates histone 
H2AX (γH2AX) and many other proteins involved in repair and checkpoint 
signaling. RPA binds the resected single-stranded DNA and is subsequently 
replaced by the recombinase RAD51. The RAD51-nucleoprotein filament 
facilitates strand invasion to the homologous double-stranded DNA 
template of the sister chromatid, allowing DNA synthesis from the sister 
template and subsequent resolution of the recombined DNA strands. 
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Yeast and mammalian SWI/SNF complexes have been implicated in both 
NHEJ and HR, as is also discussed in several previous reviews9,10,38,53. 
Depletion or inactivation of SWI/SNF subunits, including the ATPases 
BRG1 and BRM and core and accessory subunits, such as BAF155, BAF170, 
ARID1A/B and ARID2, sensitizes cells to DSB-inducing agents and reduces 
HR and/or NHEJ efficiency in fluorescent reporter assays49,50,54–56. Both BRM 
and BRG1 also rapidly localize to DSB sites, either induced enzymatically 
or by laser irradiation, in a manner that appears to be dependent on 
ATM-mediated signaling and post-translational modification of histones. 
ATM promotes the damage localization of SWI/SNF by phosphorylating 
histone H2AX50 and by directly phosphorylating BRG1 and BAF17057. 
In turn, BAF170 phosphorylation increases the interaction of SWI/SNF 
subunits with the early DDR protein BRIT1/MCPH158, a protein that too 
helps recruiting SWI/SNF. Furthermore, recruitment of BRG1 to damaged 
sites was found to depend on an interaction with the tumor suppressor 
RB1 and the E2F1 transcription factor, which also localize to DSBs in an 
ATM phosphorylation-dependent manner56. Besides phosphorylation of 
histone H2AX, also H2B phosphorylation and H3 and H4 acetylation have 
been implicated in promoting the damage localization of SWI/SNF. For 
instance, BRG1 binds to damage induced γH2AX-containing nucleosomes 
by interacting with acetylated H3 histones through its bromodomain59. 
In addition, BRM recruitment to DSBs was reported to be stimulated 
by the activity of AMP-activated protein kinase, which phosphorylates 
H2B 60, and by the activity of acetyltransferases CBP/CREBBP and p300/
EP300, which acetylate histones H3 and H4 at DSBs54. Next to the catalytic 
subunits, also other components of SWI/SNF are implicated in targeting 
SWI/SNF to damaged sites.  For example, BRM recruitment to damage 
was found to depend on the SNF5, SMARCD3 and ARID1A/B subunits49. 
Thus, it is reasonable to assume that multiple mechanisms orchestrate, 
likely in a cooperative manner, the efficient recruitment to and function 
of SWI/SNF complexes at sites of DNA damage. Besides BRG1 and BRM, 
other mutually exclusive SWI/SNF subunits were shown to localize to DSB 
sites. For instance, ARID1A recruitment to DSBs depends on ATM signaling 
and direct interaction with ATR55. On the other hand, BAF180 is recruited 
independently of ATM. 
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The exact roles of SWI/SNF complexes in DSB repair remain convoluted, 
in part because of the multiple and sometimes even ambiguous activities 
that have been reported. For example, SWI/SNF may promote efficient 
damage signaling, as depletion of BRG1 and BRM was shown to reduce 
γH2AX levels early after IR50. However, other studies have reported 
increased61 or persistent62 γH2AX levels after BRG1 loss, indicative of a 
genuine repair defect. Indeed, SWI/SNF proteins are implicated in both 
NHEJ and HR, in yeast as well as mammals31,38, which further confounds 
the dissection of their precise function in DSB repair. For instance, BRM 
and ARID1A/B were shown to stimulate recruitment of NHEJ factors, such 
as KU70/KU8049,54,60, while BRG1 and ARID1A appear to promote HR-
associated DNA end resection and RPA and RAD51 loading55,56. However, 
another study suggested that BRG1, rather than affecting resection, by 
interacting with RAD52, stimulates HR by promoting the exchange of RPA 
for RAD5163. Moreover, the PBAF subunit ARID2 was reported to interact 
with RAD51 and thereby to stimulate its loading onto DNA, independently 
of BRG1, but still in complex with BAF180 and other SWI/SNF proteins62. 
These studies suggest that SWI/SNF subunits may have functions in DSB 
repair beyond its motor function.
Despite a large amount of evidence suggesting that SWI/SNF stimulates 
DSB repair, it is unclear if this necessarily involves chromatin remodeling 
to provide access for repair factors to DNA. Some observations suggest 
that SWI/SNF activity promotes chromatin relaxation after DNA damage, 
such as increased H3 occupancy observed at DSB sites after ARID1A 
depletion55 and reduced MNAse sensitivity of genomic DNA seen after 
BRM or BRG1 depletion58. However, it was also reported that deficient 
RAD51 loading due to BRG1 deficiency could be rescued by ATPase-
mutant BRG163, suggesting that this BRG1 function is independent of 
chromatin remodeling. Interestingly, instead of facilitating chromatin 
access, the PBAF complex was found to mediate transcription silencing 
near DSBs, involving polycomb complexes PRC1 and PCR2, and ATM-
dependent mono-ubiquitylation of H2A, which promotes rapid NHEJ of 
a subset of DSBs61. Strikingly, this process required the catalytic activity 
of BRG1. Thus, considering that BRM and ARID1A/B are not part of PBAF, 
the different SWI/SNF complexes may have multiple functions in DSB 
repair, including promoting NHEJ by stimulating KU70/KU80 recruitment 
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(via BAF) and chromatin remodeling-mediated transcription silencing 
(via PBAF). Moreover, SWI/SNF may promote HR by facilitating DNA end 
resection and/or RAD51 loading (via both BAF and PBAF) (Fig. 2). It thus 
seems possible that a BAFfling collection of different SWI/SNF complexes, 
some of which may even have opposing functions, are localized to or near 
DNA damage and simultaneously stimulate HR as well as NHEJ in the same 
cell. It could be that SWI/SNF complexes act in parallel at distinct sites 
dependent on the chromatin status or in concert at different distances 
with respect to the lesion. Obviously, more and innovative research is 
necessary to better understand how the proposed different mechanisms 
of recruitment and multiple activities at sites of damage are coordinated 
and which exact activities distinguish each separate SWI/SNF complex at 
sites of DSBs. 
3.2 Nucleotide excision repair 
Depletion or inactivation of SWI/SNF subunits significantly increases 
cellular sensitivity to UV and platinum drugs such as cisplatin 48,51,64, 
suggesting the involvement of SWI/SNF in NER. This versatile repair 
process detects and removes a wide range of unrelated helix-distorting 
lesions, such as bulky-adducts and drug-induced (e.g., cisplatin) crosslinks, 
as well as the main UV-induced photoproducts, cyclobutane-pyrimidine 
dimers (CPDs) and 6-4 pyrimidine-pyrimidone photoproducts (6-4PPs)65,66. 
This unique ability of the NER pathway not only protects cells against 
cancer and aging by preventing mutagenesis and genomic instability, but 
it also provides cancer cells with a defense line against chemotherapeutic 
platinum drugs67,68. 
Two distinct DNA damage recognition routes can trigger NER, depending 
on the location of DNA lesions. When RNA Polymerase II gets stalled by 
lesions in the transcribing strand of active genes, transcription-coupled 
NER (TC-NER) is initiated by the recruitment of CSB/ERCC6, CSA/ERCC8 and 
UVSSA proteins66. Lesions located anywhere in the genome are detected 
by global genome NER (GG-NER), which is initiated by the damage 
sensor complex XPC-RAD23B-CETN265,66,69. Although XPC can recognize 
a wide range of helix-distorting lesions, it requires the auxiliary function 
of the UV-DDB complex, consisting of DDB1 and DDB2, to specifically 
and efficiently recognize UV-induced photolesions, in particular CPDs. 
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Following lesion detection, the ten subunit Transcription Factor IIH (TFIIH) 
complex is recruited to damage by interacting with XPC or UVSSA70 and 
anchored through its XPB/ERCC3 and p62/GTF2H1 subunits. Using its XPD/
ERCC2 helicase subunit, TFIIH then verifies the presence of genuine NER 
substrates66,69, assisted by XPA.  XPA and RPA stabilize this intermediate 
and adequately orient the structure-specific endonucleases XPF/ERCC4-
ERCC1 and XPG/ERCC5. After dual incision, a stretch of 22-30 nucleotides 
is excised and the resulting single-stranded gap is filled by DNA synthesis 
DSB
NHEJ
ATM
Silenced transcription by 
chromatin remodeling
KU70/KU80
recruitment
PBAF BAF
STOP
GO
GTF2H1
BAF/PBAF
DSB
HR
BAF/PBAF 
End resection & RAD51 loading
Transcriptional regulation of NER gene
Verification
NER
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CtIP
MRN
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RPA
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Figure 2. SWI/SNF ATP-dependent chromatin remodeling complexes functions in DDR. (a)  PBAF 
complexes, via their chromatin remodeling activity, were found to mediate transcription silencing near DSBs, 
in an ATM-dependent way. On the other hand, BAF complexes seem to have a distinct function in promoting 
NHEJ, by stimulating the recruitment of KU70/KU80. (b) Both BAF and PBAF complexes are implicated 
in promoting HR-associated end resection and/or RPA and RAD51 loading. (c) Unlike for NHEJ and HR, 
SWI/SNF activity only indirectly affects NER. BRM- and BRG1-containing SWI/SNF complexes promote the 
expression of the NER gene, GTF2H1, which is essential for damage verification by TFIIH. In turn, verification 
is required for the assembly of late NER proteins on UV damage (XPA, RPA, ERCC1, XPF, XPG and PCNA). 
543301-L-sub01-bw-Silva
Processed on: 6-5-2020 PDF page: 162
Chapter 5
162
and finally ligated65,66,69. 
Rearrangement of the nucleosome structure following UV damage71 
has triggered intense research on a possible function of ATP-dependent 
chromatin remodelers in NER by facilitating access to DNA. Numerous 
studies based on in vitro excision repair assays have shown that 
nucleosomes form a barrier to an efficient NER reaction and that DNA 
lesions are more easily repaired on naked than on chromatinized DNA72–
74. Furthermore, the yeast SWI/SNF complex was found to increase 
accessibility and incision of damaged DNA within in vitro reconstituted 
mononucleosomes75,76, suggesting that SWI/SNF could stimulate repair 
via chromatin remodeling activity. This idea is further supported by 
several studies in yeast and mammalian cells. For instance, yeast SWI/
SNF subunits Snf5 and Snf6 were found to interact in a UV-dependent 
manner with Rad4, the yeast orthologue of XPC, and to stimulate UV-
induced chromatin relaxation77. Studies using mammalian cells have also 
provided evidence that SWI/SNF and NER proteins interact, suggestive 
of a conserved function. Unfortunately, these studies have not been 
unambiguous in providing a precise mechanism of how mammalian SWI/
SNF might be involved in NER. One study reported that BRG1 interacts 
with DDB2 in chromatin to facilitate XPC recruitment, suggesting that SWI/
SNF might stimulate lesion detection, possibly by facilitating chromatin 
access78. However, this model is challenged by several other studies 
showing that SWI/SNF promotes late NER steps rather than early lesion 
detection. For instance, BRG1 itself was reported to be recruited to UV 
damage, in an XPC-dependent way, to promote the recruitment of late 
NER factors XPG and PCNA but not of XPC79. Accordingly, knockdown of 
BRG1 and BRM was described to impair recruitment of the late NER factor 
ERCC1 to cisplatin lesions without affecting XPC51. Moreover, SNF5 was 
found to interact with XPC, but not to regulate its recruitment but rather 
that of ATM80. Finally, depletion of ARID1A/B was found to reduce XPA 
recruitment, but not XPC recruitment, to damaged DNA64. Thus, there is 
substantial evidence supporting an evolutionarily conserved role of SWI/
SNF in NER, even though contradicting findings obscure a clear deduction 
on its exact involvement.
The already challenging dissection of SWI/SNF function in NER is even 
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further convoluted since several studies have suggested that loss of SWI/
SNF subunits (BRM, BRG1, SNF5) impairs the removal of CPDs, but not of 
6-4PPs78–81. It is difficult to envision how SWI/SNF deficiency could only 
impair CPD removal when SWI/SNF promotes the recruitment of NER 
factors, such as XPC and XPG, which are crucial for the repair of both CPDs 
and 6-4PPs. However, it has been observed that a specific mutation in the 
NER gene (XPD) affects the repair of CPDs more than that of 6-4PPs82. 
In addition, DNA damage is not distributed randomly  and the repair 
kinetics of 64PPs and CPDs are dramatically different83,84. Since 6-4PPs are 
predominantly formed in internucleosomal DNA, they may not require 
chromatin remodeling by SWI/SNF to be efficiently processed. On the 
other hand, in another study it was shown that 6-4PPs removal is impaired 
after ARID1A/B depletion64.
In an attempt to gain more insight into the main role of SWI/SNF in the 
response to UV-induced DNA damage, and because most studies have 
focused on BRG1 or SNF5, we recently investigated a putative role of BRM 
in NER85. This study was also triggered by our previous finding that in the 
model organism C. elegans multiple SWI/SNF subunits, including BRG1/
BRM, SNF5, BAF180, BAF155, and ARID1A/B, are essential for optimal UV 
survival48 (and unpublished results). We found that knockdown of BRM in 
human cells impaired both GG- and TC-NER activity, to the same extent as 
did BRG1 depletion. Importantly, while recruitment of DDB2, XPC, and CSB 
to local UV damage sites was unaffected by BRM depletion, recruitment 
of proteins downstream of these damage sensors, i.e., TFIIH, XPA, and 
XPF, was severely impaired. These results are in line with the previously 
reported reduced recruitment of XPA, XPG, ERCC1, and PCNA following 
BRG1 or BRM depletion51,64,79,85. These observations thus indicate that 
SWI/SNF activity mainly facilitates late NER steps, rather than damage 
detection. Consequently, after depletion of SWI/SNF, the overall damage 
excision is reduced. 
Strikingly, we were unable to observe BRM or BRG1 recruitment to local 
sites of UV damage, even using a dedicated UV-C laser to induce a 
high local concentration of DNA damage to which regular NER proteins 
localize86. Moreover, we could also not confirm the proposed interactions 
of BRM and BRG1 with TFIIH85, nor with DDB2 and XPC (unpublished 
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results). However, following BRG1 or BRM knockdown we observed a 
significant reduction in mRNA and protein levels of the TFIIH subunit 
GTF2H1, resulting in impaired TFIIH complex assembly. These observations 
suggest that the affected NER function upon SWI/SNF depletion is merely 
an indirect consequence of impaired GTF2H1 gene expression, rather 
than a direct role of SWI/SNF in NER. Indeed, we found that both BRG1 
and BRM associate with the promoter of GTF2H1, irrespective of whether 
there is UV damage or not, corroborating the idea that SWI/SNF promotes 
the expression of GTF2H1. Since assembly and functionality of the TFIIH 
complex were shown to depend on the cellular concentration of its 
subunits87–89, it is therefore likely that reduced GTF2H1 protein levels limit 
the availability of fully assembled functional TFIIH complexes to act in 
transcription initiation and NER. Damage verification by TFIIH is crucial to 
the assembly of late NER proteins on UV damage. Thus, reduced damage 
verification as a consequence of SWI/SNF inactivation explains the 
reduced recruitment of XPA, ERCC1, XPF, XPG and PCNA to DNA damage 
and consequent hypersensitivity of cells to UV51,64,79,81,85. 
It is surprising to note that the role of SWI/SNF chromatin remodelers 
in both DSB repair and NER is rather convoluted, making it difficult, 
if not impossible, to draw a uniform mode of their action in the DDR. 
However, given the fact that the function of SWI/SNF in transcription 
regulation is also fairly ambiguous, with even opposing gene-dependent 
and chromatin-context-dependent effects, this may not be entirely 
unforeseen. Transcription regulation depends on the intricate interplay 
between cis-acting transcription-regulatory elements in the template 
DNA, availability of general and gene-specific transcription factors, 
activation by cell-intrinsic and environmental cues, post-translational 
chromatin modifications and chromatin compaction. This multi-layered 
control over gene expression likely explains the ambiguity of SWI/SNF 
(and possibly of other chromatin modifiers alike) in this process and its 
diverse and likely dynamic composition. However, unlike transcription that 
is commonly scheduled and takes place at a defined genomic locus, DNA 
repair has to occur at any given moment and anywhere in the genome90 
due to the stochasticity of DNA damage. This likely adds another degree 
of complexity, making it even more challenging to elucidate the multiple 
functions of SWI/SNF in the DDR. 
543301-L-sub01-bw-Silva
Processed on: 6-5-2020 PDF page: 165
SWI/SNF complexes in genome stability and cancer 
5
165
4. SWI/SNF, DDR and cancer
4.1 SWI/SNF and NER deficiency in cancer
Since SWI/SNF is often mutated in cancer, we aimed at understanding 
whether cells with chronic SWI/SNF deficiency also have NER defects. 
Strikingly, we noticed that GTF2H1 levels were not altered in several 
established SWI/SNF-deficient cancer cell lines regularly used in lab 
research85. To understand the cause of this unexpected observation, 
we generated CRISPR/Cas9-mediated BRM and BRG1 knockout human 
fibroblasts. Surprisingly, upon extended culturing, we found that most 
cells with a permanent knockout of either SWI/SNF ATPase have the 
ability to restore expression of GTF2H1. However, we noticed that in some 
sub-populations of cells GTF2H1 expression remains low. Accordingly, 
we noticed that sensitivity to DNA damaging agents of BRM-knockout 
cells was directly linked to the expression levels of GTF2H1, as only cells 
that retained lowered GTF2H1 expression were hypersensitive to UV and 
cisplatin. Thus, SWI/SNF inactivation creates a potential vulnerability of cells 
to DNA damaging agents, as a consequence of GTF2H1 downregulation 
(Fig. 2). Therefore, we propose that GTF2H1 expression levels could 
serve as a potential biomarker to screen SWI/SNF cancers for increased 
sensitivity to chemotherapeutics drugs, such as cisplatin, even before 
therapy begins. However, efforts are needed to test if indeed GTF2H1 
levels are reduced across primary SWI/SNF cancers and to determine its 
suitability as a predictive marker for cisplatin sensitivity. 
The ability of chronic BRM- and/or BRG1-deficient cells to adapt and 
upregulate GTF2H1 levels likely explains why established SWI/SNF-
deficient cancer cell lines do not show reduced GTF2H1 levels. Also, it 
could explain why contradicting observations exist regarding cellular 
sensitivities to DNA damage of SWI/SNF-deficient cancer cells91,92. Similar 
adaptation to the loss of one or more SWI/SNF ATPases or subunits has 
been described for other regulatory functions of SWI/SNF outside DNA 
repair. It appears that BRG1 and BRM can at least partially compensate for 
each other’s essential functions93–96, as cells with inactivating mutations 
in BRG1 strongly rely on BRM to sustain a minimal degree of SWI/
SNF functionality to support cellular viability93,94. Also, the viability of 
ARID1A mutant cancer cells strongly depends on the, otherwise non-
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essential, ARID1B subunit97. How cells compensate for the loss of BRM 
and/or BRG1, ARID1A and/or ARID1B, is yet unknown. BRM and BRG1 
are similarly distributed across regulatory regions of the genome where 
they act either cooperatively or competitively to regulate transcription98. 
Interestingly, loss of either ATPase at certain regions often leads to 
concomitant loss of the other ATPase as well. Depending on which other 
transcriptional regulators are associated with these regions, which can 
be either activating or repressing, transcription of genes can be up- or 
downregulated when SWI/SNF is inactivated. The existence of such 
multiple transcriptional control layers, including other families of ATP-
dependent chromatin remodelers, could explain why cells are able to 
(partially) compensate for the loss of SWI/SNF activity. Possibly, in time, 
GTF2H1 is also upregulated in chronic SWI/SNF-deficient cells due to the 
activity of such yet unidentified secondary transcriptional activator(s). In 
any case, identification of the compensatory mechanisms and chromatin 
regulators that lead to GTF2H1 upregulation is fundamental. Hopefully, 
such insight would allow us to exploit these compensatory mechanisms 
therapeutically by rendering SWI/SNF-deficient cancer cells specifically 
hypersensitive to DNA damaging treatments. 
Thus far, the relevance of only a selected group of SWI/SNF subunits to 
the DDR has been studied while many more subunits are found to be 
mutated or silenced in cancer (Table 1). The involvement of these subunits 
in DNA repair is not yet known, but dissecting their precise function in 
response to DNA damage could contribute to a more comprehensive 
understanding  of SWI/SNF-deficiency in cancer. Therefore, future studies 
should consider whether additional subunits are relevant to DNA repair as 
well. In addition, it is also interesting to study whether SWI/SNF is involved 
in additional DNA repair pathways as well and what its precise activity in 
each repair pathway is. For instance, besides DSB repair and NER, BRG1 
has been found to support repair of inter-strand crosslinks, together with 
BRCA1 and FANCD2, to help maintain the differentiation status of human 
mammary epithelial cells and suppress breast cancer99. Also, a stimulatory 
function in base excision repair in vitro and yeast cells was proposed100. 
However, its exact involvement in these repair pathways is even less clear 
and scrutinized than in DSB repair and NER. 
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4.2 Therapeutic perspectives 
Given the high incidence of SWI/SNF mutations in different cancers and 
their involvement in multiple DDR pathways, it would be advantageous to 
aim future studies at therapeutically exploiting defects in DNA repair due 
to SWI/SNF-deficiency. For instance, the importance of SWI/SNF to HR 
suggests that SWI/SNF-deficient cancers could be specifically treated with 
PARP inhibitors (PARPi), which efficiently and specifically kill HR-deficient 
cancers cells and are currently also clinically applied against BRCA1-deficient 
cancers101. Indeed, it was shown that ARID1A-deficiency sensitizes cancer 
cells to PARPi both in cultured cells and in vivo55. A recently published 
functional HR assay on ex vivo fresh tissue samples, RECAP102, has proven 
to reliably identify breast cancer tumors with HR-deficiency that are thus 
sensitive to PARPi treatment. Moreover, with this novel method, the use of 
PARPi could potentially be extended beyond cancers harboring germline 
mutations in BRCA1/2. Hence, it could be advantageous also to test the 
HR capacity of SWI/SNF-deficient tumors and to use this assay to predict 
their sensitivity to PARPi. To increase efficacy, such therapeutic strategies 
that exploit DDR defects may be combined with other recently discovered 
therapeutic approaches targeting other SWI/SNF-deficiency-induced 
susceptibilities. Interestingly, ARID1A-deficient cells are also vulnerable to 
other forms of treatment, such as small molecule inhibitors of HDAC6, 
whose upregulation in ARID1A-deficient ovarian cancers inactivates p53 
and protects cancer cells from apoptosis103. Also, ATR inhibitors selectively 
kill ARID1A-deficient cancer cells due to defects in TOPIIα and cell cycle 
activity that activate ATR-dependent checkpoint signaling104. Since SWI/
SNF-deficient tumors may be hypersensitive to DNA damage due to 
defects in DNA repair pathways49,85, it would thus be beneficial to consider 
combined therapeutic approaches utilizing PARP, ATR or HDAC6 inhibitors 
and cisplatin in SWI/SNF cancers. 
5. Conclusions 
Due to its many functions, it is highly plausible that SWI/SNF complexes 
affect the DDR besides merely facilitating access of repair factors to DNA 
damage.  However, it is currently a challenge to disentangle their precise 
activities in DDR from their many other cellular functions, including general 
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maintenance of chromatin architecture. We cannot yet answer with 
certainty whether different SWI/SNF complexes are specific for different 
DDR pathways, why certain subunits are more frequently associated with 
specific tumor tissues than others and whether this is relevant to genome 
stability or not. Furthermore, loss of SWI/SNF activity can be compensated 
by, at least in part, other SWI/SNF complexes or redundant mechanisms 
that take over in the absence of SWI/SNF activity. SWI/SNF-deficient 
cancer cells likely rely on these “backup” mechanisms, which could allow 
them to acquire resistance to certain cancer therapies but will also make 
them specifically vulnerable to newly developed therapies. Mapping of 
the exact contributions of SWI/SNF in DDR and its functionally redundant 
backup mechanisms is therefore crucial to understand how SWI/SNF 
inactivation promotes tumorigenesis and to develop efficient and precise 
therapies for SWI/SNF cancers. 
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Functions of ATP-dependent chromatin remodelers in 
nucleotide excision repair 
A competent DNA damage response (DDR) is vital to the maintenance 
of genome stability and human health, and defects in this response are 
intimately linked to tumorigenesis and age-related diseases. Chromatin 
often imposes a barrier to DNA-associated processes, including the repair 
of DNA. Still, DNA is accurately repaired in the chromatin environment, 
implying that chromatin provides a dynamic platform for controlled 
DNA accessibility, which allows timely changes in its structure that 
are crucial for DNA transactions to occur efficiently. Cooperatively, 
chromatin modifiers such as chromatin remodelers, histone modifiers and 
chaperones, change the chromatin landscape and transiently rearrange 
nucleosomal distribution to facilitate repair of lesions1–4.  Genetic defects 
in these chromatin modifiers, in particular in chromatin remodelers, are 
associated with different clinical disorders, including immunodeficiency, 
neurodevelopmental problems and cancer.  
It seems certain that chromatin changes occur during the UV-induced DDR 
(UV-DDR), seeing that many different chromatin remodeling proteins and 
complexes are found to act concertedly at different steps of the repair 
process2 and that changes in histone occupancy and modifications take 
place at sites of damage4–7. It is widely accepted in the field of DNA repair 
that chromatin remodelers play an important role in early chromatin 
rearrangement events that facilitate access of repair proteins to DNA 
lesions and their consequent removal2,4,8,9. In this thesis, in Chapters 210 
and 4, we studied how the SWI/SNF and CHD1 chromatin remodeling 
proteins might contribute to the maintenance of genome stability via 
their activity in promoting nucleotide excision repair (NER). Although their 
function in NER has been investigated before10–14, full understanding of 
the involvement and activity of these and other chromatin remodelers in 
the UV-DDR is still lacking. This is not surprising, given that likely most 
of these chromatin remodelers are not essential for NER but only have 
an (often redundant) regulatory role in promoting its activity. Also, most 
chromatin remodeler complexes have multiple cellular functions that can 
indirectly meddle with DNA repair mechanisms and make it challenging 
to define their function in repair. Furthermore, ATP-dependent chromatin 
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remodelers appear to have different functions in each DDR pathway2.  One 
of the major questions that is still unanswered, in particular in the field 
of mammalian NER, is whether each complex performs actual chromatin 
remodeling near the DNA lesion (before and/or after repair) or whether it 
can have other, as-of-yet uncharacterized functions.
In Chapter 210 we provide evidence for a role of SWI/SNF in transcription 
that indirectly promotes NER. Both ATPase subunits of the SWI/SNF 
complexes, BRM and BRG1, promote the expression of the essential TFIIH 
subunit GTF2H1, thereby facilitating the stability and functionality of 
the TFIIH complex, both in transcription and in NER. We were unable to 
find evidence for a direct function of SWI/SNF during the repair of UV-
induced DNA damage. However, our proposed transcriptional activity in 
promoting NER can explain observations described in literature after BRG1 
loss that seemed until now incompatible, such as the observed reduced 
recruitment of XPC, XPA, ERCC1, XPG and PCNA to DNA damage after 
BRG1 loss which ultimately results in hypersensitivity to UV10,12,15–17. The 
implications of our findings described in Chapter 210 are more extensively 
discussed in Chapter 518, where multiple emerging functions of SWI/SNF 
proteins in the DDR are described and discussed, and a link between SWI/
SNF-deficiency-induced DDR-vulnerability and precision cancer therapy 
is explored.  
Like SWI/SNF, proteins of the CHD family are well-known regulators of 
transcription19,20 and several proteins of this family have also been linked 
to the maintenance of genome stability through new roles in different 
DDR pathways21–23. Curiously, only very recently it was shown that the 
CHD1 protein functions in the DDR, specifically in an early step of the 
response to double-strand breaks (DSBs) by facilitating the recruitment 
of homologous recombination proteins24–26. Even though depletion of 
this chromatin remodeling protein was found to sensitize cells to helix-
distorting DNA crosslinks recognized and repaired by NER27, no role 
for CHD1 in the UV-DDR had been explored at the time we started our 
investigation. In Chapter 4, we show that the expression of CHD1 is 
required for optimal cell survival following UV-irradiation. Despite our 
extensive efforts, it remains unfortunately unclear how CHD1 is recruited 
to UV-C damage and whether this recruitment is related to a function in 
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NER, as is suggested by the diminished survival and unscheduled DNA 
synthesis (UDS) assays after CHD1 knockdown. Possibly, CHD1 recruitment 
precedes NER or happens independently of NER, while somehow still 
facilitating lesion excision by NER. During our investigation, a paper was 
published describing that CHD1 activity facilitates the recruitment of core 
NER factors via the displacement of XPC14. Based on our results and despite 
using similar techniques, we were unable to draw the same conclusions. 
Given these contradicting results, it would be interesting to investigate 
in more detail CHD1’s function in NER. Possibly, CHD1 is only needed 
for repair of one type of photolesions, or only in a specific chromatin 
environment. Therefore, it should be tested whether CHD1 is required for 
the removal of CPDs or 6-4PPs, using specific antibodies in IF or ELISA 
procedures28. If CHD1 is found to specifically affect only the repair of one 
type of photolesion, dedicated photolyases, specific for either CPDs or 
6-4PPs, could be used to remove the non-relevant photolesion and to 
measure if detection and repair of the other photolesion depends on 
CHD1 activity. Photolyases are proteins that, using a mechanism known 
as photo-reactivation29,30, can directly and precisely repair either CPDs or 
6-4PPs lesions in a very short amount of time (≈1 ns)31. Their discovery 
has enabled the successful identification of specific cellular responses to 
either type of UV lesions in the past30,32 and it could also be coupled to the 
investigation of CHD1 function in NER.
In Chapters 2 and 4, we used recovery of RNA synthesis after UV-induced 
damage as a measure for a function of SWI/SNF and CHD1 proteins in 
transcription-coupled NER (TC-NER). However, because transcription and 
not repair itself is measured, this assay is only an indirect indication of DNA 
repair capacity. Given the transcriptional roles of both these chromatin 
remodelers, it may be better to confirm a role in TC-NER by measuring DNA 
repair more directly. A suited assay to directly measure their involvement 
in TC-NER is the recently modified single-cell unscheduled DNA synthesis 
(UDS) assay, which has increased sensitivity when compared to a traditional 
UDS. This amplified UDS method33, performed in global-genome-NER 
(GG-NER) deficient cells, allows the quantification of TC-NER activity only. 
It would be useful to use this improved assay to test whether depletion 
of CHD1, SWI/SNF or any other chromatin remodeler affects repair by TC-
NER and whether it also or only affects transcription restart. 
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Furthermore, using an unbiased proteomics approach, it should be 
investigated which proteins interact with CHD1 after UV irradiation. This 
might help to identify the histones and/or NER proteins that are regulated 
by CHD1 during the UV-DDR, such that its precise activity can be better 
understood. One possibility would be to perform stable isotope labeling 
of amino acids in culture, which our lab has applied successfully in the past 
to identify UV-dependent interactions within NER34–36. However, because 
our first attempt utilizing this approach did not yield any clear candidates 
(results not shown) and because chromatin remodelers like CHD1 may 
rather have transient than strong interactions, a better option could be to 
use biotin ligase catalyzed proximity labeling37.
Perhaps the most interesting question would be to investigate whether 
CHD1 facilitates lesion removal by NER by making chromatin more 
accessible through chromatin remodeling. For other chromatin remodelers 
implicated in NER, like INO8038, ALC139 and SMARCA540, this is also still 
an unanswered question. Specific mutations in CHD1 that inactivate 
its ATPase activity could be used to determine whether its chromatin 
remodeling activity is required for its recruitment to damaged DNA and 
the stimulation of UDS and survival. Besides, an assay should be developed 
which faithfully measures chromatin remodeling at sites of UV damage. 
For histone chaperones HIRA and FACT, SNAP-tag technology41 and 
quantitative fluorescence imaging techniques6 have been used to measure 
histone dynamics in chromatin after UV. Possibly, these technologies 
could be applied to study chromatin remodeling by CHD1 as well. Another 
possibility would be to measure chromatin accessibility in a locus-
specific manner, which would be advantageous to determine whether 
CHD1 is needed in specific chromatin environments. For instance, using 
the chromatin accessibility by quantitative PCR (CHART-qPCR) assay42, 
chromatin remodeling events could be detected with high sensitivity in 
specific chromatin environments damaged by UV. The assay is based on the 
principle that accessible chromatin is more easily digested by nucleases, 
coupled with analysis of the nuclease- and mock-treated samples for a 
particular gene by qPCR42 (Fig. 1). In this assay, UV-induced chromatin 
remodeling, to create more accessible chromatin, would show a larger 
Cq shift between digested and undigested samples. It would be valuable 
to test the accessibility of different chromatin environments before and 
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after UV irradiation, in CDH1- proficient or deficient cells. If successfully 
implemented to observe local UV-induced chromatin changes, this 
approach could be used to screen for the involvement of other chromatin 
remodelers as well and scrutinize their potential chromatin remodeling 
functions in NER. 
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Figure 1. Schematic representation of the CHART-qPCR for the identification of chromatin remodelers 
with chromatin remodeling function in the UV-DDR. Nuclei extracted from cells either mock- or UV-
treated, are incubated with nucleases. If UV-irradiation induces the remodeling of chromatin, DNA with be 
more accessible to cleavage near the lesion. This increased digestion can be detected by qPCR as an increase 
in the Cq value. Depletion of chromatin remodelers prior to UV-irradiation will show their participation in this 
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Spatiotemporal control of damage handover in GG-NER
More than 30 repair factors are involved in lesion removal by NER; their 
assembly into functional repair complexes and subsequent dissociation - 
once their job is done - must be tightly controlled both in time and space, 
for proper damage handover, efficient repair and to avoid illegitimate or 
uncontrolled action of repair enzymes, such as non-scheduled incisions. 
This dynamic repair complex assembly and disassembly likely involves 
regulation by post-translation modifications (PTMs) to control localization, 
interactions, timely function and/or stability of individual repair proteins. 
Ubiquitylation is one example of a PTM that is particularly important 
during damage detection in both TC- and GG-NER43. In Chapter 3, we 
studied damage detection by and handover from the DDB2-associated 
CRL4 ubiquitin-ligase complex (CRL4DDB2). This complex is a key player in 
the UV-induced ubiquitylation in GG-NER, whose main targets are XPC, the 
E3 ubiquitin ligase adaptor DDB2 itself and core histones44–47. Interestingly, 
ubiquitylation of both GG-NER sensors has distinct consequences, as it 
decreases DDB2’s affinity for damaged DNA but increases that of XPC 
(in vitro)44,48. Furthermore, CRL4DDB2-mediated ubiquitylation was shown to 
promote DDB2 release from damaged chromatin via the recruitment of 
the segregase VCP, an ATP-driven molecular chaperone that interacts with 
K48-linked polyubiquitin chains and directs its clients to the proteasomal 
degradation machinery46,49–51. Yet, it is surprising that only DDB2 – and not 
XPC as well – is degraded following CRL4DDB2-mediated ubiquitylation44. 
Thus, the same type of PTM can differentially regulate the activity and fate 
of DNA repair proteins. 
PTMs other than ubiquitylation have also been reported to control both 
DDB2 and XPC activity, including  SUMOylation52–54, phosphorylation55 and 
PARylation39,56–58. For example, it has been proposed that the poly(ADP-
ribose) polymerase 1 (PARP1) collaborates with DDB2 to increase the 
efficiency of lesion recognition by GG-NER; likely PARP1 directly PARylates 
DDB2, thus regulating its binding capacity, interaction with XPC and/or 
degradation after UV damage39,57. Because PARP1 inhibition was found 
chromatin rearrangement event(s). The spheres in the top panel represent the nucleosomal core histones. 
The star depicts the position of the UV-induced DNA damage.
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to block chromatin remodeling of UV-damaged chromatin59, it is also 
conceivable that PARP1 activity promotes chromatin remodeling39 during 
damage detection, which might influence the binding of DDB2 and XPC. 
Therefore, it would be interesting to investigate how these PTMs may be 
controlling the dynamic damage handover between NER initiation and 
verification factors. This could be achieved by using specific inhibitors, 
such as PARP inhibitors, or by identification of the modified residues by 
mass spectrometry, followed by their mutation. 
Although it has been known for a long time that DDB2 is degraded upon 
DNA damage induction44,48,60, the exact function of this degradation 
has thus far been unclear. Based on our results described in Chapter 
3, we propose that a main function of DDB2 degradation is to prevent 
its excessive rebinding of lesions, which could potentially interfere 
with assembly of the downstream NER damage verification machinery. 
However, DDB2 degradation after DNA damage induction may also serve 
other purposes. Different views on the function of DDB2 degradation can 
be found in literature. For example, DDB2 degradation was suggested 
to be necessary for DDB1 release, so that DDB1 is available for its other 
(many) cellular functions61. Also, DDB2 was described to function as a 
molecular switch in the regulation of the cell cycle after DNA damage 
through the regulation of p21 levels62–64. Expression of both DDB2 and p21 
is induced by p5365–67, yet p21 blocks cell cycle progression and inhibits 
apoptosis while DDB2 appears to attenuate this barrier by promoting p21 
degradation after DNA damage62,64. UV-induced DDB2 degradation has 
never been coupled to this proposed role in cell fate decision after DNA 
damage; however, it would be interesting to investigate a potential link 
between these two. In Chapter 3, we show that if lesions are not repaired, 
the continuous targeting of DDB2 molecules causes a reduction in total 
cellular DDB2 levels. Thus, DDB2 levels could serve as an indicator of the 
cell’s capacity to repair UV-damage by GG-NER and accordingly favor 
apoptosis or cell cycle arrest. This hypothesis could be tested by inhibiting 
UV-induced DDB2 degradation, for instance using the DDB2 mutants 
described in Chapter 3, and testing whether this differentially impacts the 
cell cycle and/or apoptosis after UV irradiation.
Our hypothesis that DDB2 degradation is needed to facilitate the stable 
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access of XPC to DNA damage (and, thereafter, downstream NER proteins) 
appears most plausible as it is supported by multiple independent 
observations from different labs46. For instance, experiments with NER 
proteins immobilized on chromatin have suggested that DDB2 and TFIIH 
association with XPC is mutually exclusive68. Also, in silico modeling based 
on in vitro structures suggests that DDB2 and XPC cannot stably bind 
the same lesion simultaneously69–72. In addition to the ubiquitylation of 
DDB2, which reduces its affinity for DNA and recruits VCP, we describe 
in Chapter 3 that TFIIH recruitment promotes DDB2 dissociation. This 
exchange between DDB2 and TFIIH promotes the stable binding of XPC 
because actual recognition of DNA damage by XPC is likely reciprocally 
stimulated by its interaction with TFIIH and, in particular, by its damage 
verification activity. Our results, presented in Chapter 3, show that the 
stable binding of XPC also requires XPA, which stimulates the helicase 
activity of TFIIH subunit XPD via the dissociation of the CAK sub-complex73. 
Therefore, in accord with literature, we propose the scenario in which TFIIH 
first interacts with XPC, via its XPB subunit, after which the blocking of XPD 
helicase activity by a lesion allows the TFIIH subunit GTF2H1 to interact 
with XPC71. This damage verification further stabilizes the XPC-TFIIH-DNA 
complex. It would be interesting to confirm this by investigating DDB2 
and XPC recruitment and binding to DNA damage in cells with specific 
XPD helicase mutations that block the damage verification but leave 
XPB-mediated TFIIH recruitment still intact. With the advance of CRISPR/
Cas9-based gene-editing technologies, it will be possible to introduce 
such mutations in cell lines expressing fluorescent XPC, DDB2, and XPB 
and investigate this using similar imaging technologies as described in 
Chapter 3. 
 
DDB2 dissociation from DNA, to make room for downstream NER factors, 
is as essential as its association to DNA damage, because defects in both 
lead to similar impairment in XPC recruitment. Interestingly, in a similar 
manner, the dissociation of XPC from the damage verification complex, 
promoted by the RNF111-mediated ubiquitylation of XPC, is required for 
the loading of the downstream endonuclease XPG53. These observations 
strongly indicate that the spatiotemporal organization of the repair 
reaction is regulated by a dynamic and intricate interplay between the 
comings and goings of different repair factors. Based on this, we believe 
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that cooperation and competition between NER factors and PTMs are 
inherent to the efficient step-by-step damage handover (and, ultimately, 
damage excision). Therefore, future research should focus on this interplay 
by determining whether similar cooperation/competition interactions 
exist between other NER factors. To this end, a multidisciplinary approach 
would be most advantageous, combining results from cell imaging 
experiments, as described in this thesis, with structural data from new 
emerging technologies such as crosslinking mass spectrometry and cryo-
electron microscopy. 
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Summary 
DNA, the carrier of genetic information, is vulnerable to chemical changes 
induced by endogenous and exogenous DNA damaging agents that 
compromise its integrity and functionality. Daily, each of our cells is 
confronted with over ten thousand new DNA lesions with immediate and 
long-term effects, if left unrepaired. In particular, DNA damage greatly 
contributes to genome instability by interfering with essential genome 
processes, such as replication and transcription. This can also result in 
mutations that alter our genetic information and favor tumorigenesis. 
Accumulation of DNA damage and their consequent disturbance of vital 
genome processes are also important contributors to aging. It is thus 
crucial to safeguard DNA’s integrity by swiftly repairing damaged DNA at 
any genomic location and time. 
Cells are equipped with a DNA damage response (DDR), which comprises 
several signaling pathways and specialized DNA repair mechanisms, to 
avoid the fallouts of DNA injuries. An overview of the different DNA repair 
mechanisms is presented in Chapter 1, with a focus on nucleotide excision 
repair (NER) - which is the main topic of this thesis. Additionally, the role 
of chromatin and chromatin-modifying enzymes as integral players in the 
UV-induced DDR is described. NER is an essential DNA damage repair 
mechanism that removes a wide variety of helix-distorting DNA lesions, 
including UV-light and platinum drug-induced lesions. NER thereby 
protects healthy cells against cancer and aging, but unfortunately also 
cancer cells against chemotherapy.
SWI/SNF chromatin remodelers, which are frequently found mutated in 
cancer, have been implicated in transcription and multiple DDR pathways, 
including NER. In particular, chromatin remodeling via the SWI/SNF ATPase 
BRG1 is hypothesized to stimulate NER, but the precise involvement of 
BRG1 and its less scrutinized cognate ATPase BRM in DDR remains unclear. 
In Chapter 2, we describe how SWI/SNF-promotes NER by regulating the 
transcription of GTF2H1, a subunit of the basal transcription and NER 
factor TFIIH, which is necessary for the stable assembly of functional TFIIH 
complexes. Intriguingly, we observed that cancer cells and fibroblasts 
with permanent loss or inactivation of BRM or BRG1 can adapt to restore 
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normal GTF2H1 expression (in a SWI/SNF-independent manner). The DNA 
damage sensitivity of SWI/SNF-deficient cells therefore correlates with 
GTF2H1 expression, i.e., only cells that retain low GTF2H1 are hypersensitive 
to DNA damaging agents. This finding exposes a vulnerability of SWI/
SNF-mutated cancers which could be specifically targeted to increase 
chemotherapy effectiveness. 
In Chapter 3, we investigated the mechanism of damage handover 
between NER factors during global genome NER (GG-NER). GG-NER is 
initiated by the DNA damage sensor XPC, which upon lesion detection 
recruits the TFIIH complex to verify the presence of the lesion. A second 
DNA damage sensor, DDB2, is required for XPC to efficiently detect and 
bind to highly cytotoxic UV-induced photolesions that only minimally 
distort the DNA helix. We show that the recruitment, stable binding and 
dissociation of DDB2, XPC and TFIIH is tightly coordinated for proper 
damage handover. Although DDB2 lesion binding assists XPC recruitment, 
its timely dissociation – not its UV-induced degradation -, is required 
for DNA damage handover to XPC and coincides with the arrival of the 
TFIIH complex and the formation of a stable XPC-TFIIH complex. At 
least three main events contribute to the timely dissociation of DDB2: 
1) its ubiquitylation (by the CRL4DDB2 E3 ubiquitin ligase complex) upon 
binding to DNA damage; 2) active extraction from damaged DNA by the 
ubiquitin-dependent VCP/p97 segregase; and 3) the recruitment of TFIIH, 
which intriguingly appears to exchange with DDB2. Furthermore, DDB2 
homeostasis is regulated by its proteasomal degradation upon ubiquitin-
mediated dissociation, which lowers effective DDB2 concentrations, 
preventing the continuous DDB2 rebinding to lesions, which interferes with 
stable XPC and TFIIH binding. Finally, we found that XPC stable association 
with DNA damage is reciprocally stimulated by its interaction with and 
damage verification by TFIIH. Our study demonstrates that reciprocal 
and ubiquitin-controlled coordination between damage recognition and 
verification factors (i.e., their competitive and cooperative binding to DNA 
lesions) provides precise spatiotemporal control of damage handover in 
GG-NER. 
It is widely accepted in the field of DNA repair that chromatin remodelers 
play an important role in early chromatin rearrangement events that 
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facilitate access of repair proteins to DNA lesions and their consequent 
removal. CHD1 is an ATP-dependent chromatin remodeling protein 
recently implicated in the repair of double-strand breaks. Interestingly, 
loss of this chromatin remodeler also sensitizes cells to a range of DNA 
damaging agents that induce helix-distorting DNA crosslinks mainly 
processed by NER. Thus, in Chapter 4, we sought to explore a putative role 
of CHD1 in NER. We found that CHD1 activity promotes resistance to UV-
induced DNA damage likely by facilitating the loading of the NER-specific 
endonucleases onto damaged DNA. Because we did not find any defect in 
the recruitment of DNA damage detection and lesion verification proteins 
to UV-damaged DNA, we hypothesize that CHD1 promotes progression 
from lesion verification to excision. Intriguingly, CHD1 recruitment to 
UV-induced damage appears to be independent of NER and we were 
unable to identify how CHD1 promotes NER. Nonetheless, given the high 
mutation frequency of CHD1 in prostate cancer, it is important to channel 
further efforts into understanding the role of CHD1 in the DDR. Such 
efforts may be valuable for the detection of DDR vulnerabilities caused by 
CHD1 deficiency that can be exploited for therapeutic approaches. 
In Chapter 5, we offer a broad overview of the emerging roles of the SWI/
SNF chromatin remodeling complexes in response to DNA damage. Here 
we also discuss how the interplay between defects in chromatin remodelers 
and DDR contribute to tumorigenesis. Additionally, we reflected on SWI/
SNF’s tumor suppressor functions, their deficiency in cancer and, perhaps 
most excitingly, the potential exploitation of DDR-related vulnerabilities 
that arise from SWI/SNF dysfunction for precision medicine. 
Finally, in Chapter 6, the main data and results of Chapters 2, 3 and 4 
are summarized and discussed, accompanied by contemplations of future 
research endeavors to gain more insight in the function and fine-tuning of 
GG-NER, as well as to dissect CHD1’s molecular function in NER. 
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DNA, de drager van genetische informatie, is vatbaar voor chemische 
veranderingen die door endogene en exogene DNA-beschadigende 
stoffen worden veroorzaakt en die de integriteit en de functionaliteit van 
DNA aantasten. Dagelijks worden al onze cellen geconfronteerd met meer 
dan tienduizend nieuwe DNA-beschadigingen die, als ze niet worden 
gerepareerd, zowel directe als meer langdurige consequenties hebben. 
DNA-schade veroorzaakt vooral genoominstabiliteit doordat het essentiële 
genoomprocessen zoals replicatie en transcriptie verstoort. Hierdoor leidt 
DNA-schade tot het ontstaan van mutaties, die de genetische informatie 
veranderen, waardoor tumoren kunnen ontstaan. Ophoping van DNA-
schade en langdurige verstoring van genoomprocessen dragen ook in 
belangrijke mate bij aan het proces van veroudering. Daarom is het erg 
belangrijk dat de integriteit van DNA continu wordt beschermd door 
beschadigd DNA snel te repareren, ongeacht de genomische locatie. 
De DNA-schade respons (in het Engels: DNA damage response; DDR) is 
een belangrijk mechanisme in cellen om de negatieve effecten van DNA-
schade te voorkomen en bestaat uit verschillende signaaltransductiepaden 
en gespecialiseerde DNA-reparatiemechanismen. In hoofdstuk 1 
wordt een overzicht van de verschillende DNA-reparatiemechanismen 
gepresenteerd, met een focus op nucleotide excisie reparatie (NER) 
- het hoofdonderwerp van dit proefschrift -, en wordt de rol van 
chromatine en chromatine-modificerende enzymen als integrale spelers 
in de UV-geïnduceerde DDR besproken. NER is een essentieel DNA-
reparatiemechanisme en kan een  scala van verschillende soorten helix-
verstorende DNA-schade verwijderen, inclusief het type schade dat door 
UV-licht en door platina-bevattende medicijnen wordt veroorzaakt. Op 
deze manier beschermt NER gezonde cellen tegen kanker en veroudering, 
maar helaas ook kankercellen tegen chemotherapie.
SWI/SNF-chromatine-reorganisatiefactoren, die vaak gemuteerd zijn in 
kanker, zijn betrokken bij transcriptie en meerdere DDR-mechanismen, 
waaronder NER. Zo wordt gedacht dat de chromatine-reorganisatie SWI/
SNF-ATPase BRG1 NER stimuleert, maar de precieze functie van BRG1 en 
van zijn minder goed onderzochte verwante ATPase BRM in de DDR blijft 
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onduidelijk. In hoofdstuk 2 beschrijven we hoe SWI/SNF NER bevordert 
door de transcriptie van GTF2H1 te reguleren. Het GTF2H1 eiwit is 
onderdeel van de basale transcriptie- en NER-factor TFIIH en nodig voor 
de stabiele opbouw van functionele TFIIH-complexen. Tot onze verbazing 
vonden we dat kankercellen en fibroblasten met permanente inactivering 
of verlies van BRM of BRG1 zich kunnen aanpassen en de normale 
GTF2H1-expressie kunnen herstellen (op een SWI/SNF-onafhankelijke 
manier). Om die reden correleert de DNA-schadegevoeligheid van SWI/
SNF-deficiënte cellen met het expressie niveau van GTF2H1; alleen cellen 
die een lage GTF2H1-expressie behouden, zijn overgevoelig voor DNA-
schade-inducerende agentia. Deze bevinding onthult een kwetsbaarheid 
van SWI/SNF-gemuteerde kankers, die specifiek zou kunnen worden 
uitgebuit om de effectiviteit van chemotherapie te verhogen.
In hoofdstuk 3 onderzochten we DNA-schadeoverdracht tussen 
NER-factoren tijdens globaal-genoom NER (GG-NER). GG-NER wordt 
geïnitieerd door de DNA-schadesensor XPC, die na detectie het TFIIH-
complex rekruteert om de aanwezigheid van schade te verifiëren. Een 
tweede DNA-schadesensor, DDB2, is nodig om XPC op efficiënte manier 
cytotoxische UV-geïnduceerde typen DNA-schade te laten detecteren 
en binden, omdat deze typen DNA-schade de DNA-helix maar minimaal 
destabiliseren. We laten zien dat de rekrutering, stabiele binding en 
dissociatie van DDB2, XPC en TFIIH nauwkeurig worden gecoördineerd 
voor een optimale DNA-schadeoverdracht. Hoewel binding van DNA-
schade door DDB2 XPC-rekrutering bevordert, is ook een tijdige dissociatie 
(maar niet de UV-geïnduceerde afbraak) nodig voor de overdracht van 
DNA-schade aan XPC en valt deze samen met de rekrutering van het 
TFIIH-complex en de vorming van een stabiel XPC-TFIIH-complex. Ten 
minste drie processen dragen bij aan de tijdige dissociatie van DDB2: 1) de 
ubiquitylatie van DDB2 (door het CRL4DDB2 E3 ubiquitine ligase complex) 
bij binding aan DNA-schade; 2) actieve extractie uit beschadigd DNA 
door de ubiquitine-afhankelijke VCP/p97 segregase; en 3) de rekrutering 
van het TFIIH-complex, dat lijkt uit te wisselen met DDB2. Verder wordt 
de DDB2-homeostase gereguleerd door proteasomale afbraak na de 
ubiquitine-gemedieerde dissociatie, waardoor de effectieve DDB2 
concentratie wordt verlaagd. Hierdoor wordt het continu opnieuw binden 
van DDB2 aan DNA-schade voorkomen, dat mogelijk de stabiele binding 
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van XPC en TFIIH verstoort. Ten slotte hebben we gevonden dat stabiele 
binding van XPC aan DNA-schade wederzijds wordt gestimuleerd door 
interactie met en schade-verificatie door TFIIH. Onze studie toont het 
bestaan aan van een nauwkeurige ruimtelijke en tijdelijke coördinatie van 
schadeoverdracht tijdens GG-NER door de wederzijdse en door ubiquitine 
gecontroleerde coördinatie tussen schadedetectie- en -verificatiefactoren 
(d.w.z. door hun competitieve en coöperatieve binding aan DNA-schade).
In het DNA-reparatieveld wordt algemeen aangenomen dat chromatine-
reorganisatiefactoren belangrijk zijn om al vroeg in het reparatieproces 
de toegang van reparatie-eiwitten tot DNA-schade te reguleren, om op 
die manier de verwijdering van DNA-schade te vergemakkelijken. CHD1 is 
een ATP-afhankelijke chromatine-reorganisatie-eiwit waarvan onlangs is 
gevonden dat het betrokken is bij de reparatie van dubbelstrengs DNA-
breuken. Cellen zonder dit chromatine-reorganisatie-eiwit zijn echter 
ook gevoelig voor agentia die helix-destabiliserende DNA-crosslinks 
veroorzaken, die voornamelijk door NER worden gerepareerd. Daarom 
hebben we in hoofdstuk 4 gezocht naar een mogelijke rol van CHD1 
in NER. We vonden dat CHD1 beschermend werkt tegen door UV-
geïnduceerde typen DNA-schade, waarschijnlijk doordat CHD1 helpt 
bij de rekrutering van NER-specifieke endonucleasen op beschadigd 
DNA. Omdat we geen enkel defect vonden in de rekrutering van DNA-
schade-, en verificatie-eiwitten naar UV-beschadigd DNA, denken we 
dat CHD1 specifiek de voortgang van DNA-schade verificatie naar DNA-
schade-verwijdering tijdens NER stimuleert. CHD1-rekrutering naar UV-
geïnduceerde DNA-schade is echter onafhankelijk van NER en we konden 
ook niet vaststellen hoe CHD1 precies NER bevordert. Gezien de hoge 
mutatiefrequentie van CHD1 in prostaatkanker is het echter belangrijk om 
de rol van CHD1 in de DDR beter te begrijpen. Dit kan waardevol zijn voor 
het opsporen van DDR-gerelateerde zwakheden veroorzaakt door CHD1-
deficiëntie die kunnen worden gebruikt voor therapeutische doeleinden.
In hoofdstuk 5 geven we een algemeen overzicht van de recentelijk 
gevonden functies van SWI/SNF-chromatine-reorganisatiefactoren in de 
respons tegen DNA-schade. We beschrijven hoe defecten in chromatine-
reorganisatiefactoren en in de DDR samen kunnen bijdragen aan het 
ontstaan van tumoren. Verder beschouwen we de tumorsuppressorfuncties 
543301-L-sub01-bw-Silva
Processed on: 6-5-2020 PDF page: 200
Appendix
200
van SWI/SNF en hoe deficiënties daarin bijdragen tot het ontstaan van 
kanker. Tevens, en dat is misschien nog wel het meest opwindende, 
hebben we de mogelijke therapeutische exploitatie van DDR-gerelateerde 
zwakheden veroorzaakt door SWI/SNF-dysfunctie beschreven.
Ten slotte worden in hoofdstuk 6 de belangrijkste data en resultaten 
van de hoofdstukken 2, 3 en 4 samengevat en besproken, samen met 
de mogelijkheden om in de toekomst verder onderzoek te verrichten om 
meer inzicht te verkrijgen in de functie en precieze coördinatie van GG-
NER alsmede in de moleculaire functie van CHD1 in NER.
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“If you hear a voice within you say ‘you cannot paint’, them by all means 
paint, and that voice will be silenced.” 
― Vincent van Gogh
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